US20070073127A1 - Parameter compensated physiological monitor - Google Patents

Parameter compensated physiological monitor Download PDF

Info

Publication number
US20070073127A1
US20070073127A1 US11/604,499 US60449906A US2007073127A1 US 20070073127 A1 US20070073127 A1 US 20070073127A1 US 60449906 A US60449906 A US 60449906A US 2007073127 A1 US2007073127 A1 US 2007073127A1
Authority
US
United States
Prior art keywords
parameter
physiological
blood
tissue site
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/604,499
Inventor
Massi Kiani
Mohamed Diab
Ammar Al-Ali
Walter Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/671,179 external-priority patent/US7274955B2/en
Application filed by Individual filed Critical Individual
Priority to US11/604,499 priority Critical patent/US20070073127A1/en
Publication of US20070073127A1 publication Critical patent/US20070073127A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14539Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring pH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14535Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring haematocrit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0242Operational features adapted to measure environmental factors, e.g. temperature, pollution
    • A61B2560/0247Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value
    • A61B2560/0252Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value using ambient temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/01Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue

Definitions

  • Pulse oximetry is a noninvasive, easy to use, inexpensive procedure for measuring the oxygen saturation level of arterial blood. Pulse oximeters perform a spectral analysis of the pulsatile component of arterial blood in order to determine the relative concentration of oxygenated hemoglobin, the major oxygen carrying constituent of blood, and reduced hemoglobin. These instruments have gained rapid acceptance in a wide variety of medical applications, including surgical wards, intensive care units, general wards and home care by providing early detection of decreases in the arterial oxygen supply, which reduces the risk of accidental death and injury.
  • FIG. 1 illustrates a pulse oximetry system 100 having a sensor 110 and a monitor 150 .
  • the sensor 110 has emitters 120 and a detector 130 .
  • the emitters 120 typically consist of a red light emitting diode (LED) and an infrared LED that project light through blood vessels and capillaries underneath a tissue site, such as a fingernail bed.
  • the detector 130 is typically a photodiode positioned opposite the LEDs so as to detect the emitted light as it emerges from the tissue site.
  • a pulse oximetry sensor is described in U.S. Pat. No. 6,088,607 entitled “Low Noise Optical Probe,” which is assigned to Masimo Corporation, Irvine, Calif. and incorporated by reference herein.
  • the monitor 150 has drivers 152 , a sensor front-end 154 , a signal processor 155 , a display driver 157 , a display 158 and a controller 159 .
  • the drivers 152 alternately activate the emitters 120 as determined by the controller 159 .
  • the front-end 154 conditions and digitizes the resulting current generated by the detector 130 , which is proportional to the intensity of the detected light.
  • the signal processor 155 inputs the conditioned detector signal and determines oxygen saturation based upon the differential absorption by arterial blood of the two wavelengths projected by the emitters 120 .
  • a ratio of detected red and infrared intensities is calculated by the signal processor 155 , and an arterial oxygen saturation value is empirically determined based on the ratio obtained, as described with respect to FIGS. 2-3 , below.
  • the display driver 157 and associated display 158 indicate a patient's oxygen saturation along with pulse rate.
  • the Beer-Lambert law provides a simple model that describes a tissue site response to pulse oximetry measurements.
  • the Beer-Lambert law states that the concentration c i of an absorbent in solution can be determined by the intensity of light transmitted through the solution, knowing the pathlength d ⁇ , the intensity of the incident light I o, ⁇ , and the extinction coefficient E i, ⁇ at a particular wavelength ⁇ .
  • the Beer-Lambert law assumes photon scattering in the solution is negligible.
  • the minimum number of discrete wavelengths that are required to solve EQS. 1-2 are the number of significant absorbers that are present in the solution. For pulse oximetry, it is assumed that wavelengths are chosen such that there are only two significant absorbers, which are oxygenated hemoglobin (HbO 2 ) and reduced hemoglobin (Hb).
  • FIG. 2 illustrates top-level computation functions for the signal processor 155 ( FIG. 1 ), described above.
  • pulse oximetry measurements are conventionally made at a red wavelength corresponding to 660 nm and an infrared wavelength corresponding to 940 nm. At these wavelengths, reduced hemoglobin absorbs more red light than oxygenated hemoglobin, and, conversely, oxygenated hemoglobin absorbs more infrared light than reduced hemoglobin.
  • pulse oximetry relies on the pulsatile nature of arterial blood to differentiate hemoglobin absorption from absorption of other constituents in the surrounding tissues.
  • Light absorption between systole and diastole varies due to the blood volume change from the inflow and outflow of arterial blood at a peripheral tissue site.
  • This tissue site also comprises skin, muscle, bone, venous blood, fat, pigment, etc., each of which absorbs light. It is assumed that the background absorption due to these surrounding tissues is invariant and can be ignored. That is, the sensor signal generated by the pulse-added arterial blood is isolated from the signal generated by other layers including tissue, venous blood and baseline arterial blood.
  • the signal processor 155 computes ratios 215 , 265 of the AC portions 212 , 262 of the detected red (RD) 201 and infrared (IR) 206 signals with respect to the DC portions 214 , 264 of the detected signals 201 , 206 .
  • Computations of these AC/DC ratios 215 , 265 provide relative absorption measures that compensate for variations in both incident light intensity and background absorption and, hence, are responsive only to the hemoglobin in the arterial blood.
  • RD/IR ( Red AC /Red DC )/( IR AC /IR DC ) (3)
  • SpO 2 desired oxygen saturation
  • RD/IR red-over-infrared, ratio-of-ratios
  • FIG. 3 shows a graph 300 depicting the relationship between RD/IR and SpO 2 .
  • This relationship can be approximated from Beer-Lambert's Law, described above. However, it is most accurately determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of oxygen saturation.
  • the result can be depicted as a curve 310 , with measured values of RD/IR shown on a x-axis 302 and corresponding saturation values shown on an y-axis 301 .
  • this empirical relationship can be stored in a read-only memory (ROM) for use as a look-up table 280 ( FIG. 2 ) so that SpO 2 can be directly read-out from an input RD/IR measurement.
  • ROM read-only memory
  • a parameter compensated physiological monitor advantageously utilizes one or more parameters that are not considered in conventional physiological monitoring in order to derive a more accurate physiological measurement. Parameters may be input from various sources, such as multiple parameter sensors, additional sensors, external instrumentation and manual input devices. A compensated physiological measurement accounts for these parameters by various mechanisms including modification of calibration data, correction of uncompensated physiological measurements, multidimensional calibration data, sensor wavelength modification in conjunction with wavelength-dependent calibration data, and modification of physiological measurement algorithms.
  • a parameter compensated physiological monitor has a primary input from which a spectral characteristic of a tissue site can be derived.
  • the monitor also has a secondary input from which at least one parameter can be determined.
  • a compensation relationship of the spectral characteristic, the parameter and a compensated physiological measurement is determined.
  • a processor is configured to output the compensated physiological measurement in response to the primary input and the secondary input utilizing the compensation relationship.
  • a parameter compensated physiological monitoring method includes the steps of inputting a sensor signal responsive to a spectral characteristic of a tissue site and deriving a physiological measurement from the characteristic. Other steps include obtaining a parameter, wherein the physiological measurement has a dependency on the parameter and determining a relationship between the spectral characteristic and the parameter that accounts for the dependency. A further step is compensating the physiological measurement for the parameter utilizing the relationship.
  • a parameter compensated physiological monitor has a primary input for determining a spectral characteristic associated with a tissue site.
  • the monitor also has a secondary input means for determining a parameter that is relevant to measuring oxygen saturation at the tissue site and a compensation relationship means for relating the spectral characteristic, the parameter and an oxygen saturation measurement.
  • FIG. 1 is a block diagram of a prior art pulse oximeter
  • FIG. 2 is a top-level functional diagram of conventional pulse oximetry signal processing
  • FIG. 3 is an exemplar graph of a conventional calibration curve
  • FIG. 4 is a top-level block diagram of a parameter compensated physiological monitor having sensor, external instrument and manual parameter inputs;
  • FIG. 5 is a block diagram of a parameter compensated pulse oximeter having a manual parameter input
  • FIG. 6 is a block diagram of a parameter compensated pulse oximeter having a multi-wavelength sensor along with sensor site temperature and external instrument pH parameter inputs;
  • FIG. 7 is a top-level functional block diagram of a compensation relationship having spectral characteristic and parameter inputs and a compensated physiological measurement output;
  • FIG. 8A is a functional block diagram of parameter compensated signal processing incorporating calibration data modification
  • FIG. 8B is a functional block diagram of compensated pulse oximetry incorporating an SpO 2 parameter input and SpO 2 measurement feedback;
  • FIG. 8C is a functional block diagram of pulse oximetry calibration data modification
  • FIGS. 9 A-D are graphs of one embodiment of calibration data modification utilizing Bezier curves
  • FIG. 10A is a functional block diagram of parameter compensated signal processing incorporating physiological measurement correction
  • FIG. 10B is a functional block diagram of compensated pulse oximetry incorporating a hemoglobin constituent correction for a SpO 2 measurement
  • FIG. 11 is a functional block diagram of parameter compensated signal processing incorporating multidimensional calibration data
  • FIG. 12 is a graph of a multidimensional calibration surface for a compensated physiological measurement
  • FIG. 13A is a functional block diagram of parameter compensated signal processing incorporating sensor wavelength modification and wavelength-dependent calibration data
  • FIG. 13B is a functional block diagram of compensated pulse oximetry incorporating a null parameter and SpO 2 feedback.
  • FIG. 14 is a functional block diagram of compensated pulse rate measurements.
  • FIG. 4 illustrates a general interface architecture including a primary sensor input and parameter inputs from sensors, external instruments and manual entry.
  • FIGS. 5-6 illustrate particular pulse oximetry embodiments of FIG. 4 .
  • FIG. 5 illustrates a two-wavelength sensor input along with manual parameter inputs.
  • FIG. 6 illustrates a multiple wavelength sensor allowing derived parameters, a sensor temperature element input for a site temperature parameter, and an external instrument input for a pH parameter.
  • FIG. 7 illustrates a general parameter compensation signal processing function.
  • FIGS. 8-9 illustrate a compensated physiological measurement computed from a spectral characteristic utilizing parameter modified calibration data.
  • FIGS. 10 A-B illustrate a compensated physiological measurement computed from parameter dependent correction of an uncompensated physiological measurement.
  • FIGS. 11-12 illustrate a compensated physiological measurement computed from a spectral characteristic and input parameters utilizing multidimensional calibration data.
  • FIGS. 13 A-B illustrate a compensated physiological measurement resulting from parameter dependent sensor wavelength and calibration data modification.
  • FIG. 14 illustrates a compensated physiological measurement computed from a parameter modified algorithm.
  • a pulse oximeter has a manual input compensation parameter, such as described with respect to FIG. 5 .
  • the manual input may be, say, a blood gas derived parameter, such as carboxyhemoglobin (HbCO) or methemoglobin (MetHb) to name just a few.
  • HbCO carboxyhemoglobin
  • MetHb methemoglobin
  • FIG. 4 illustrates a parameter compensated physiological monitor 400 having a sensor interface 410 , an external instrument interface 420 and a user interface 430 .
  • the sensor interface 410 connects to one or more tissue site sensors 10 , which may be optical or non-optical devices configured to provide invasive or noninvasive measurements of tissue site properties.
  • the sensor interface 410 has a primary input 412 and one or more sensor parameter inputs 414 .
  • the primary input 412 is adapted to provide tissue site spectral characteristics via sensor optical elements.
  • a sensor parameter input 414 is adapted to provide other tissue site characteristics via optical or nonoptical elements.
  • the primary input 412 is a detector response to at least two emitter wavelengths after transmission through or reflection from a tissue site, from which the physiological monitor 400 may derive at least a conventional physiological measurement, such as an oxygen saturation value, as described with respect to FIGS. 1-3 above.
  • a conventional physiological measurement such as an oxygen saturation value
  • the sensor 10 utilizes more than two wavelengths so that the physiological monitor 400 may derive, for example, the concentrations of other blood constituents in addition to oxygen saturation, such as total hematocrit (Hct).
  • Hct total hematocrit
  • the same sensor or a different sensor may also provide other tissue site measurements, such as temperature, on the sensor parameter input 414 .
  • An example of this embodiment is described with respect to FIG. 6 , below.
  • an external instrument interface 420 connects to one or more external instruments 20 , which may monitor physiological or nonphysiological properties, invasively or noninvasively, from the sensor tissue site or from other portions of a patient or a patient's immediate environment.
  • the external instrument 20 is a pH monitor, as described with respect to FIG. 6 , below.
  • a user interface 430 accepts one or more manual input parameters 432 .
  • the user interface 430 may be a keyboard input operating in conjunction with a user display, which may range from a small character display to a CRT providing a computer-generated graphical user interface (GUI).
  • GUI computer-generated graphical user interface
  • the manual inputs may be any information related to, for instance, a patient, a patient's immediate environment, or a patient's medical history.
  • a manual input 432 may indicate the presence of an implant device, such as a pacemaker or an intra aortic balloon pump (IABP).
  • IABP intra aortic balloon pump
  • a manual input of blood gas measurements such as are obtainable from a CO-oximeter, is provided.
  • the sensor interface 410 , external instrument interface 420 and user interface 430 each provide inputs to the signal processor 440 .
  • the signal processor utilizes the primary input 412 and one or more parameter inputs 403 to generate a compensated physiological measurement 442 .
  • the compensated physiological measurement 442 is an SpO 2 value that is derived from both the primary input 412 and the parameter inputs 403 .
  • FIG. 5 illustrates one embodiment of a parameter compensated physiological monitor 400 ( FIG. 4 ).
  • a parameter compensated pulse oximeter 500 has sensor 510 and manual inputs.
  • drivers 562 activate emitters 520 that project two wavelengths into a tissue site, and a detector 540 responsive to the emitters 520 provides a primary input 542 to a sensor front-end 564 , as described above.
  • a user interface 565 accepts manual inputs 550 such as temperature (T), pH, Hct, HbCO and MetHb, etc.
  • the sensor front-end 564 and user interface 565 output to the signal processor 566 a detector signal along with the manually input parameters.
  • the signal processor 566 computes a compensated SpO 2 measurement from the detector signal and these parameters, as described with respect to FIGS. 7-13 , below.
  • the compensated SpO 2 measurement is then displayed 567 , 568 in a manner similar to that described above with respect to FIG. 1 .
  • FIG. 6 illustrates another embodiment of a parameter compensated physiological monitor 400 ( FIG. 4 ).
  • a parameter compensated multiple wavelength monitor 600 has inputs from a sensor 610 and an external pH monitor 650 .
  • the sensor 610 has multiple wavelength emitters 620 and a site temperature element 630 . Multiple wavelengths may be achieved, for example, by utilizing multiple LEDs each manufactured for a specific wavelength according to the number of wavelengths desired. Alternatively, one or more LEDs having drive current dependent wavelengths may be utilized, where the drive current is controlled to shift between multiple wavelengths.
  • the site temperature element 630 provides a site temperature parameter input to the sensor front-end 664 .
  • the site temperature element 630 is a thermistor located on the sensor 610 proximate the emitters 620 or proximate the detector 640 .
  • the detector 640 provides a multiple wavelength signal output that is combined with a site temperature output to a sensor front-end 664 .
  • An instrument interface 665 is adapted to input pH readings from the pH monitor 650 .
  • the sensor drivers 662 provide multiplexed activation of the multiple emitters 620 as determined by the controller 669 .
  • the signal processor 666 accepts outputs from the sensor front-end 664 and the instrument interface 665 .
  • the signal processor 666 computes an SpO 2 measurement from the detector signal along with a sensor parameter, such as Hct for example, utilizing the multiple wavelength signal from the detector 640 . Further, the signal processor 666 derives a compensated SpO 2 measurement from the site temperature, pH, and Hct parameters, as described with respect to FIGS. 7-13 , below. The compensated SpO 2 measurement is then displayed 667 , 668 in a manner similar to that described above.
  • a pulse oximetry sensor 610 may be improved for use in conjunction with a parameter compensated pulse oximeter by increasing the number of wavelengths projected by the emitters 620 , which allows the resolution of more than two blood constituents, as described above. Further, the sensor 610 may be improved by adding the capability to measure various parameters, such as site temperature. Alternatively, as shown in FIG. 5 , pulse oximeter performance can be improved at reduced costs by utilizing simple sensors in conjunction with other instrumentation and/or manual inputs to provide additional input parameters.
  • the sensor 610 may also have an information element (not shown) that describes information regarding the sensor.
  • the information element provides the monitor 660 with information regarding available wavelengths for the emitters 620 and/or information regarding the temperature element 630 , such as the resistance-temperature characteristics of a thermistor.
  • An information element is described in U.S. Pat. No. 6,011,986 entitled “Manual And Automatic Probe Calibration,” assigned to Masimo Corporation, Irvine, Calif. and incorporated by referenced herein.
  • FIG. 7 illustrates a compensation relationship function 700 that the signal processor 440 ( FIG. 4 ) performs.
  • the compensation relationship 700 has a spectral characteristic input or inputs 702 and parameter inputs 704 and generates a compensated physiological measurement output 708 .
  • the spectral characteristic 702 is derived from the primary input 412 ( FIG. 4 )
  • the parameters 704 are received from the interfaces 410 - 430 ( FIG. 4 )
  • the physiological measurement 708 is provided at the signal processor output 442 ( FIG. 4 ), as described above.
  • FIGS. 8-14 illustrate various embodiments of the compensation relationship 700 .
  • FIGS. 8-9 illustrate a compensation relationship incorporating parameter modification of baseline calibration data.
  • FIGS. 10 A-B illustrate parameter correction of an uncompensated physiological measurement.
  • FIGS. 11-12 illustrate parameter incorporation into multidimensional calibration data.
  • FIGS. 13 A-B illustrate parameter modification of sensor wavelength and selection of wavelength-dependent calibration data.
  • FIG. 14 illustrates parameter modification of physiological measurement algorithms.
  • FIG. 8A illustrates a compensation relationship 800 having a look-up table 810 , baseline calibration data 830 and a calibration data modification function 820 .
  • the compensation relationship 800 has a spectral characteristic input 802 , parameter inputs 804 and a physiological measurement output 808 , as described above.
  • the calibration data modification 820 advantageously responds to the parameters 804 to select, modify, derive or otherwise determine from the baseline calibration data 830 a calibration data input 822 to the look-up table 810 .
  • the look-up table 810 uses the calibration data 822 to determine the physiological measurement 808 corresponding to the spectral characteristic 802 .
  • the calibration data 822 may also be responsive to feedback of the physiological measurement 808 .
  • the baseline calibration data 830 may be determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of the physiological measurement and associated parameters. Also, all or part of the look-up table 810 , calibration data modification 820 and baseline calibration data 830 may be replaced by or combined with a mathematical formula or algorithm, theoretically or experimentally derived, that is used to compute calibration data or used to directly compute the physiological measurement from the spectral characteristic and parameter inputs.
  • FIGS. 8 B-C describe one pulse oximeter embodiment of the compensation relationship 800 ( FIG. 8A ).
  • the blood gas compensation relationship 851 has an RD/IR input 802 and generates an SpO 2 output 808 utilizing baseline calibration data 880 that is modified according to an input value of arterial oxygen saturation SpO 2 .
  • the compensation relationship 851 has a calibration data modification function 871 that provides modified calibration data 872 to a look-up table 860 , as described with respect to FIG. 8A , above.
  • the calibration data modification 871 has comparison 891 and sensitivity filter 893 functions that input to modification rules 895 that operate on the baseline calibration data 882 to provide modified calibration data 872 .
  • the comparison 891 determines a difference between SpO 2 804 and SpO 2 808 so that the compensation relationship 871 can function to reduce the discrepancy between blood gas measurement and pulse oximeter measurements of oxygen saturation.
  • the responsiveness to blood gas measurements is determined by a sensitivity filter 893 and sensitivity adjustment 809 .
  • calibration data modification may require multiple blood gas input values over a range of saturation values and/or consistency within a tolerance range before calibration data is modified.
  • calibration data modification can be less sensitive to more frequently occurring normal saturation values and more sensitive to the less frequently occurring low saturation values.
  • the sensitivity filter 893 may have a blood gas input 804 so that responsiveness varies with the range of blood gas sample values.
  • calibration data may be piecewise modified according to ranges of saturation values, so that an entire range of calibration data is not affected by blood gas measurements that are limited to a certain range of saturation values.
  • Saturation Range is a range of blood gas measurements and a corresponding portion of the calibration curve to be replaced or modified.
  • Number of Samples is the number of blood gas measurements required within the corresponding Saturation Range before a calibration curve modification or replacement is made.
  • Sample Tolerance is the deviation allowed between measured SpO 2 and measured SpO 2 for a particular blood gas measurement to be considered.
  • the saturation ranges may be in 5% increments, i.e. 100-95%, 95-90%, etc.
  • the number of samples may be, say, 4 for saturation measurements above 75% and 1 for saturation measurements below 75%.
  • the modification rules 895 may operate on the baseline calibration data to select one of a family of calibration curves, determine the direction and amount of shift in a calibration curve, modify the shape of a calibration curve, rotate a calibration curve around a selected point on the curve, specify one or more points from which a calibration curve may be derived, or a combination of these actions.
  • a pulse oximeter may be calibrated on site for individual patients, for improved accuracy as compared with total reliance on empirical calibration data derived from many individuals. Calibration curve modification in response to blood gas measurements is described in further detail with respect to FIGS. 9 A-D, below.
  • FIGS. 9 A-D illustrate calibration data modification utilizing a Bezier curve.
  • a Bezier curve is a simple cubic equation defined by four points including the end points and two control points, as is well-known in the art.
  • a calibration curve 910 such as described with respect to FIG. 3 , above can be approximated as a Bezier curve with an associated first control point 920 and second control point 930 .
  • the initial Bezier curve 910 ( FIG. 9A ) can be modified in response to a blood gas measurement providing a first calibration point 940 at a relatively high saturation value.
  • a modified calibration curve 911 can be derived in response to the first calibration point 940 by repositioning the first and second control points 920 - 930 so that the modified calibration curve 911 more closely approximates the first calibration point 940 than the original calibration curve 910 without significantly altering the original calibration curve 910 ( FIG. 9A ) within saturation ranges away from the first calibration point 940 .
  • the modified calibration curve 911 ( FIG. 9B ) can be modified in response to a second calibration point 950 at a relatively low saturation value.
  • a modified calibration curve 912 can be derived in response to the first and second calibration points 940 - 950 by again repositioning the first and second control points 920 - 930 so that the modified calibration curve 912 more closely approximates the calibration points 940 - 950 .
  • the modified calibration curve 912 ( FIG. 9C ) can be modified yet again in response to a third calibration point 960 .
  • a modified calibration curve 913 can be derived in response to the three calibration points 940 - 960 by further repositioning the control points 920 - 930 so that the modified calibration curve 913 more closely approximates the calibration points 940 - 960 .
  • Multiple calibration points may be accommodated by curve-fitting algorithms well-known in the art, such as a least-means-squared computation of the error between the modified calibration curve and the calibration points, as one example.
  • Other polynomials curves may be used to derive modified calibration curves, and two or more sections of Bezier curves or other polynomial curves can be used to represent a modified calibration curve.
  • FIG. 10A illustrates a measurement correction compensation relationship 1000 having a look-up table 1010 , calibration data 1020 , and a measurement correction function 1030 .
  • the compensation relationship 1000 differs from the compensation relationship 800 ( FIG. 8A ) described above in that, an uncompensated physiological measurement 1018 is calculated and corrected to yield a compensated physiological measurement 1008 . This contrasts with a compensated physiological measurement being directly derived from a spectral characteristic and parameters, as described with respect to FIG. 8A , above.
  • FIG. 10B illustrates an upgrade compensation relationship 1001 embodiment of the compensation relationship 1000 ( FIG. 10A ) described above.
  • the compensation relationship 1001 advantageously upgrades the uncompensated oxygen saturation measurement of a conventional pulse oximeter.
  • the look-up table 1010 and calibration curve 1020 may be as described with respect to FIGS. 2-3 , above.
  • the measurement correction 1031 is a look-up table having a correction data set as input, where the correction data set is determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of oxygen saturation and associated parameters.
  • the measurement correction 1031 is a mathematical formula or algorithm that directly computes a compensated SpO 2 output from uncompensated SpO 2 and parameter inputs.
  • the measurement correction is a combination of look-up table and mathematical formula or algorithm.
  • the compensation parameters may be, for example, one or more of T, pH, Hct, HbCO, MetHb, to name a few.
  • FIG. 11 illustrates a multidimensional calibration function 1100 having a look-up table 1110 and associated multidimensional calibration data 1120 .
  • the look-up table 1110 has a spectral characteristic input 1112 , such as RD/IR, and one or more compensation parameters 1114 , such as T, pH, Hct, HbCO, MetHb, etc., as described with respect to FIG. 7 , above.
  • the look-up table 1110 provides a physiological measurement output 1118 , such as a compensated oxygen saturation value, also as described with respect to FIG. 7 , above.
  • the look-up table 1110 may function as a calibration surface 1210 ( FIG.
  • the multidimensional calibration data 1120 may be determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of the physiological measurement and associated parameters. Also, the look-up table 1110 and calibration data 1120 may be replaced by or combined with a mathematical formula or algorithm, theoretically or experimentally derived, used to directly compute a physiological measurement from spectral characteristic and parameter inputs.
  • FIG. 12 is a three-dimensional graph 1200 illustrating the look-up table calibration function described with respect to FIG. 11 , above.
  • the graph 1200 has an x-axis 1201 representing derived spectral characteristic values, a y-axis 1203 representing a parameter value, and a z-axis 1205 representing physiological measurement values that result from locating a position on the surface 1210 corresponding to a combination of spectral characteristic and parameter values.
  • the three-dimensional graph 1200 may be extended to accommodate multiple parameters, so as to create a calibration surface in multidimensional hyperspace.
  • a blood gas measurement of HbCO and/or MetHb is manually entered into a pulse oximeter and utilized to generate a compensated value of SpO 2 .
  • conventional pulse oximetry utilizes two wavelengths, assuming that Hb and HbO 2 are the only significant absorbers.
  • HbCO and MetHb may also be significant absorbers at RD and IR wavelengths.
  • the presence of significant concentrations of HbCO and MetHb have different effects on a conventional pulse oximeter estimate of oxygen saturation.
  • HbO 2 and HbCO have similar extinctions at the RD wavelength, as do MetHb and Hb.
  • HbCO is relatively transparent whereas MetHb has greater extinction than the other hemoglobins.
  • HbCO is counted as an oxygen carrying form of hemoglobin, causing a conventional pulse oximeter to overestimate oxygen saturation.
  • MetHb increases, RD/IR tends to unity and SpO 2 tends to a constant (e.g. 85%) regardless of oxygen saturation.
  • a manually entered value of HbCO and or MetHb is used as a parameter in conjunction with the functions described above with respect to any of FIGS. 7-11 , so as to distinguish these hemoglobin species from HbO 2 and Hb, providing a more accurate, HbCO and/or MetHb compensated, value of SpO 2 .
  • FIG. 13A illustrates a wavelength compensation relationship 1300 having a look-up table 1310 , wavelength-dependent calibration data 1320 , and a wavelength determination function 1330 .
  • the wavelength compensation relationship 1300 advantageously changes sensor wavelength to generate a wavelength-compensated physiological measurement output 1308 .
  • the look-up table 1310 has a spectral characteristic input 1302 and generates a physiological measurement output 1308 utilizing the wavelength-dependent calibration data 1320 .
  • the wavelength determination function 1330 has parameter 1304 inputs and, in one embodiment, a feedback input of the physiological measurement 1308 , and provides a sensor wavelength selection output 1338 .
  • the wavelength selection output 1338 provides a calibration data 1320 input for selecting wavelength-dependent portions of the calibration data 1320 .
  • the wavelength control output 1338 is a feedback path to a controller 669 ( FIG. 6 ) and/or drivers 662 ( FIG. 6 ), for example, so as to modify the wavelength of a multiple-wavelength sensor 610 ( FIG. 6 ).
  • FIG. 13B illustrates one advantageous pulse oximeter embodiment of the wavelength compensation relationship 1300 .
  • FIG. 13B illustrates an oxygen saturation dependent wavelength compensation relationship 1301 having a null parameter input 1304 ( FIG. 13A ), i.e. no parameter is used, and a wavelength control output 1338 that is dependent on the SpO 2 output 1308 .
  • the wavelength determination function 1330 has SpO 2 1308 as input and generates a wavelength selection output 1338 , accordingly.
  • the wavelength selection output 1338 determines particular red and IR wavelengths to be used for conventional pulse oximetry measurements and a corresponding one of a family of wavelength dependent calibration curves 1320 .
  • sensor wavelength can be dynamically adjusted based upon saturation levels, e.g. a first red and/or IR wavelength may be used in low saturation conditions and a second red and/or IR wavelength may be used in normal saturation conditions.
  • FIG. 14 illustrates parameter compensation of pulse rate measurements.
  • the compensation relationship 1400 includes a pulse rate calculation 1410 having a plethysmograph input 1402 and providing a pulse rate measurement output 1408 .
  • the pulse rate calculation 1410 also has one or more parameter inputs 1404 , such as a manual input indicating the presence of an implant device, such as an IABP or a pacemaker, or the presence of an arrhythmia.
  • the parameter input is used to alter the pulse rate calculation 1410 so as to derive a more accurate pulse rate measurement 1408 .
  • the criteria for determining a physiologically acceptable pulse on the plethysmograph input 1402 such as aspects of the pulse shape, may be altered according to the parameter input 1404 .
  • Pulse rate calculations are described in U.S. Pat. No. 6,463,311 entitled “Plethysmograph Pulse Recognition Processor,” which is assigned to Masimo Corporation, Irvine, Calif. and incorporated by reference herein.

Abstract

A monitor has an optical input from which a spectral characteristic can be derived. The monitor also has a non-optical input from which a parameter can be determined. A compensation relationship is determined for the spectral characteristic based on the parameter. A physiological measurement is determined based on the spectral characteristic and the compensation relationship.

Description

    REFERENCE TO RELATED APPLICATIONS
  • The present application is a continuation of U.S. patent application Ser. No. 10/714,526, filed on Nov. 14, 2003 entitled “Parameter Compensated Pulse Oximeter”; which claims the benefit U.S. Provisional Application No. 60/426,638, filed Nov. 16, 2002, entitled “Parameter Compensated Physiological Monitor,” and is a continuation-in-part of U.S. patent application Ser. No. 10/671,179, filed Sep. 25, 2003, entitled “Parameter Compensated Pulse Oximeter,” which claims the benefit of U.S. Provisional Application No. 60/413,494, filed Sep. 25, 2002, entitled “Parameter Compensated Pulse Oximeter.” The present application incorporates the disclosures of the foregoing applications herein by reference.
  • BACKGROUND OF THE INVENTION
  • Pulse oximetry is a noninvasive, easy to use, inexpensive procedure for measuring the oxygen saturation level of arterial blood. Pulse oximeters perform a spectral analysis of the pulsatile component of arterial blood in order to determine the relative concentration of oxygenated hemoglobin, the major oxygen carrying constituent of blood, and reduced hemoglobin. These instruments have gained rapid acceptance in a wide variety of medical applications, including surgical wards, intensive care units, general wards and home care by providing early detection of decreases in the arterial oxygen supply, which reduces the risk of accidental death and injury.
  • FIG. 1 illustrates a pulse oximetry system 100 having a sensor 110 and a monitor 150. The sensor 110 has emitters 120 and a detector 130. The emitters 120 typically consist of a red light emitting diode (LED) and an infrared LED that project light through blood vessels and capillaries underneath a tissue site, such as a fingernail bed. The detector 130 is typically a photodiode positioned opposite the LEDs so as to detect the emitted light as it emerges from the tissue site. A pulse oximetry sensor is described in U.S. Pat. No. 6,088,607 entitled “Low Noise Optical Probe,” which is assigned to Masimo Corporation, Irvine, Calif. and incorporated by reference herein.
  • Also shown in FIG. 1, the monitor 150 has drivers 152, a sensor front-end 154, a signal processor 155, a display driver 157, a display 158 and a controller 159. The drivers 152 alternately activate the emitters 120 as determined by the controller 159. The front-end 154 conditions and digitizes the resulting current generated by the detector 130, which is proportional to the intensity of the detected light. The signal processor 155 inputs the conditioned detector signal and determines oxygen saturation based upon the differential absorption by arterial blood of the two wavelengths projected by the emitters 120. Specifically, a ratio of detected red and infrared intensities is calculated by the signal processor 155, and an arterial oxygen saturation value is empirically determined based on the ratio obtained, as described with respect to FIGS. 2-3, below. The display driver 157 and associated display 158 indicate a patient's oxygen saturation along with pulse rate.
  • The Beer-Lambert law provides a simple model that describes a tissue site response to pulse oximetry measurements. The Beer-Lambert law states that the concentration ci of an absorbent in solution can be determined by the intensity of light transmitted through the solution, knowing the pathlength dλ, the intensity of the incident light Io,λ, and the extinction coefficient Ei,λ at a particular wavelength λ. In generalized form, the Beer-Lambert law is expressed as: I λ = I 0 , λ - d λ · μ a , λ ( 1 ) μ a , λ = i = 1 n ɛ i , λ · c i ( 2 )
    where μa,λ is the bulk absorption coefficient and represents the probability of absorption per unit length. The Beer-Lambert law assumes photon scattering in the solution is negligible. The minimum number of discrete wavelengths that are required to solve EQS. 1-2 are the number of significant absorbers that are present in the solution. For pulse oximetry, it is assumed that wavelengths are chosen such that there are only two significant absorbers, which are oxygenated hemoglobin (HbO2) and reduced hemoglobin (Hb).
  • FIG. 2 illustrates top-level computation functions for the signal processor 155 (FIG. 1), described above. In particular, pulse oximetry measurements are conventionally made at a red wavelength corresponding to 660 nm and an infrared wavelength corresponding to 940 nm. At these wavelengths, reduced hemoglobin absorbs more red light than oxygenated hemoglobin, and, conversely, oxygenated hemoglobin absorbs more infrared light than reduced hemoglobin.
  • In addition to the differential absorption of hemoglobin derivatives, pulse oximetry relies on the pulsatile nature of arterial blood to differentiate hemoglobin absorption from absorption of other constituents in the surrounding tissues. Light absorption between systole and diastole varies due to the blood volume change from the inflow and outflow of arterial blood at a peripheral tissue site. This tissue site also comprises skin, muscle, bone, venous blood, fat, pigment, etc., each of which absorbs light. It is assumed that the background absorption due to these surrounding tissues is invariant and can be ignored. That is, the sensor signal generated by the pulse-added arterial blood is isolated from the signal generated by other layers including tissue, venous blood and baseline arterial blood.
  • As shown in FIG. 2, to isolate the pulsatile arterial blood, the signal processor 155 (FIG. 1) computes ratios 215, 265 of the AC portions 212, 262 of the detected red (RD) 201 and infrared (IR) 206 signals with respect to the DC portions 214, 264 of the detected signals 201, 206. Computations of these AC/ DC ratios 215, 265 provide relative absorption measures that compensate for variations in both incident light intensity and background absorption and, hence, are responsive only to the hemoglobin in the arterial blood. Further, a ratio of the normalized absorption at the red wavelength over the normalized absorption at the infrared wavelength is computed:
    RD/IR=(Red AC /Red DC)/(IR AC/IRDC)  (3)
    The desired oxygen saturation (SpO2) 282 is then computed empirically from this “red-over-infrared, ratio-of-ratios” (RD/IR) 272. That is, the RD/IR output 272 is input to a look-up table 280 containing empirical data 290 relating RD/IR to SpO2, as described with respect to FIG. 3, below.
  • FIG. 3 shows a graph 300 depicting the relationship between RD/IR and SpO2. This relationship can be approximated from Beer-Lambert's Law, described above. However, it is most accurately determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of oxygen saturation. The result can be depicted as a curve 310, with measured values of RD/IR shown on a x-axis 302 and corresponding saturation values shown on an y-axis 301. In a pulse oximeter device, this empirical relationship can be stored in a read-only memory (ROM) for use as a look-up table 280 (FIG. 2) so that SpO2 can be directly read-out from an input RD/IR measurement. For example, an RD/IR value of 1.0 corresponding to a point 312 on the calibration curve 310 indicates a resulting SpO2 value of approximately 85%.
  • SUMMARY OF THE INVENTION
  • Conventional pulse oximetry measurements, for example, depend on a predictable, empirical correlation between RD/IR and SpO2. The relationship between oxygen saturation and tissue spectral characteristics, such as RD absorbance as compared with IR absorbance, however, vary with other parameters such as site temperature, pH and total hematocrit (Hct), to name just a few, that are not accounted for in the conventional photon absorbance model. A parameter compensated physiological monitor advantageously utilizes one or more parameters that are not considered in conventional physiological monitoring in order to derive a more accurate physiological measurement. Parameters may be input from various sources, such as multiple parameter sensors, additional sensors, external instrumentation and manual input devices. A compensated physiological measurement accounts for these parameters by various mechanisms including modification of calibration data, correction of uncompensated physiological measurements, multidimensional calibration data, sensor wavelength modification in conjunction with wavelength-dependent calibration data, and modification of physiological measurement algorithms.
  • One aspect of a parameter compensated physiological monitor has a primary input from which a spectral characteristic of a tissue site can be derived. The monitor also has a secondary input from which at least one parameter can be determined. A compensation relationship of the spectral characteristic, the parameter and a compensated physiological measurement is determined. A processor is configured to output the compensated physiological measurement in response to the primary input and the secondary input utilizing the compensation relationship.
  • A parameter compensated physiological monitoring method includes the steps of inputting a sensor signal responsive to a spectral characteristic of a tissue site and deriving a physiological measurement from the characteristic. Other steps include obtaining a parameter, wherein the physiological measurement has a dependency on the parameter and determining a relationship between the spectral characteristic and the parameter that accounts for the dependency. A further step is compensating the physiological measurement for the parameter utilizing the relationship.
  • Another aspect of a parameter compensated physiological monitor has a primary input for determining a spectral characteristic associated with a tissue site. The monitor also has a secondary input means for determining a parameter that is relevant to measuring oxygen saturation at the tissue site and a compensation relationship means for relating the spectral characteristic, the parameter and an oxygen saturation measurement.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a block diagram of a prior art pulse oximeter;
  • FIG. 2 is a top-level functional diagram of conventional pulse oximetry signal processing;
  • FIG. 3 is an exemplar graph of a conventional calibration curve;
  • FIG. 4 is a top-level block diagram of a parameter compensated physiological monitor having sensor, external instrument and manual parameter inputs;
  • FIG. 5 is a block diagram of a parameter compensated pulse oximeter having a manual parameter input;
  • FIG. 6 is a block diagram of a parameter compensated pulse oximeter having a multi-wavelength sensor along with sensor site temperature and external instrument pH parameter inputs;
  • FIG. 7 is a top-level functional block diagram of a compensation relationship having spectral characteristic and parameter inputs and a compensated physiological measurement output;
  • FIG. 8A is a functional block diagram of parameter compensated signal processing incorporating calibration data modification;
  • FIG. 8B is a functional block diagram of compensated pulse oximetry incorporating an SpO2 parameter input and SpO2 measurement feedback;
  • FIG. 8C is a functional block diagram of pulse oximetry calibration data modification;
  • FIGS. 9A-D are graphs of one embodiment of calibration data modification utilizing Bezier curves;
  • FIG. 10A is a functional block diagram of parameter compensated signal processing incorporating physiological measurement correction;
  • FIG. 10B is a functional block diagram of compensated pulse oximetry incorporating a hemoglobin constituent correction for a SpO2 measurement;
  • FIG. 11 is a functional block diagram of parameter compensated signal processing incorporating multidimensional calibration data;
  • FIG. 12 is a graph of a multidimensional calibration surface for a compensated physiological measurement;
  • FIG. 13A is a functional block diagram of parameter compensated signal processing incorporating sensor wavelength modification and wavelength-dependent calibration data;
  • FIG. 13B is a functional block diagram of compensated pulse oximetry incorporating a null parameter and SpO2 feedback; and
  • FIG. 14 is a functional block diagram of compensated pulse rate measurements.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • Overview
  • Parameter compensated physiological monitoring is described below with respect to monitor interface architectures (FIGS. 4-6) and monitor signal processing functions (FIGS. 7-14). FIG. 4 illustrates a general interface architecture including a primary sensor input and parameter inputs from sensors, external instruments and manual entry. FIGS. 5-6 illustrate particular pulse oximetry embodiments of FIG. 4. FIG. 5 illustrates a two-wavelength sensor input along with manual parameter inputs. FIG. 6 illustrates a multiple wavelength sensor allowing derived parameters, a sensor temperature element input for a site temperature parameter, and an external instrument input for a pH parameter.
  • FIG. 7 illustrates a general parameter compensation signal processing function. FIGS. 8-9 illustrate a compensated physiological measurement computed from a spectral characteristic utilizing parameter modified calibration data. FIGS. 10A-B illustrate a compensated physiological measurement computed from parameter dependent correction of an uncompensated physiological measurement. FIGS. 11-12 illustrate a compensated physiological measurement computed from a spectral characteristic and input parameters utilizing multidimensional calibration data. FIGS. 13A-B illustrate a compensated physiological measurement resulting from parameter dependent sensor wavelength and calibration data modification. FIG. 14 illustrates a compensated physiological measurement computed from a parameter modified algorithm.
  • The interface architectures according to FIGS. 4-6 may each support signal processing functions according to FIGS. 7-14. As just one of many examples and embodiments, a pulse oximeter has a manual input compensation parameter, such as described with respect to FIG. 5. The manual input may be, say, a blood gas derived parameter, such as carboxyhemoglobin (HbCO) or methemoglobin (MetHb) to name just a few. This parameter is utilized to select, modify, derive or otherwise determine a calibration curve or other form of calibration data so as to compute a more accurate measure of SpO2.
  • Parameter Compensation Architecture
  • FIG. 4 illustrates a parameter compensated physiological monitor 400 having a sensor interface 410, an external instrument interface 420 and a user interface 430. The sensor interface 410 connects to one or more tissue site sensors 10, which may be optical or non-optical devices configured to provide invasive or noninvasive measurements of tissue site properties. The sensor interface 410 has a primary input 412 and one or more sensor parameter inputs 414. The primary input 412 is adapted to provide tissue site spectral characteristics via sensor optical elements. A sensor parameter input 414 is adapted to provide other tissue site characteristics via optical or nonoptical elements.
  • In one embodiment, the primary input 412 is a detector response to at least two emitter wavelengths after transmission through or reflection from a tissue site, from which the physiological monitor 400 may derive at least a conventional physiological measurement, such as an oxygen saturation value, as described with respect to FIGS. 1-3 above. An example of this embodiment is described with respect to FIG. 5, below. In another embodiment, the sensor 10 utilizes more than two wavelengths so that the physiological monitor 400 may derive, for example, the concentrations of other blood constituents in addition to oxygen saturation, such as total hematocrit (Hct). The same sensor or a different sensor may also provide other tissue site measurements, such as temperature, on the sensor parameter input 414. An example of this embodiment is described with respect to FIG. 6, below.
  • Also shown in FIG. 4, an external instrument interface 420 connects to one or more external instruments 20, which may monitor physiological or nonphysiological properties, invasively or noninvasively, from the sensor tissue site or from other portions of a patient or a patient's immediate environment. In one embodiment, the external instrument 20 is a pH monitor, as described with respect to FIG. 6, below.
  • Further shown in FIG. 4, a user interface 430 accepts one or more manual input parameters 432. As an example, the user interface 430 may be a keyboard input operating in conjunction with a user display, which may range from a small character display to a CRT providing a computer-generated graphical user interface (GUI). The manual inputs may be any information related to, for instance, a patient, a patient's immediate environment, or a patient's medical history. In one embodiment, a manual input 432 may indicate the presence of an implant device, such as a pacemaker or an intra aortic balloon pump (IABP). In another embodiment, a manual input of blood gas measurements, such as are obtainable from a CO-oximeter, is provided.
  • Additionally shown in FIG. 4, the sensor interface 410, external instrument interface 420 and user interface 430 each provide inputs to the signal processor 440. The signal processor utilizes the primary input 412 and one or more parameter inputs 403 to generate a compensated physiological measurement 442. In one embodiment, the compensated physiological measurement 442 is an SpO2 value that is derived from both the primary input 412 and the parameter inputs 403.
  • FIG. 5 illustrates one embodiment of a parameter compensated physiological monitor 400 (FIG. 4). A parameter compensated pulse oximeter 500 has sensor 510 and manual inputs. In particular, drivers 562 activate emitters 520 that project two wavelengths into a tissue site, and a detector 540 responsive to the emitters 520 provides a primary input 542 to a sensor front-end 564, as described above. A user interface 565 accepts manual inputs 550 such as temperature (T), pH, Hct, HbCO and MetHb, etc. The sensor front-end 564 and user interface 565 output to the signal processor 566 a detector signal along with the manually input parameters. The signal processor 566 computes a compensated SpO2 measurement from the detector signal and these parameters, as described with respect to FIGS. 7-13, below. The compensated SpO2 measurement is then displayed 567, 568 in a manner similar to that described above with respect to FIG. 1.
  • FIG. 6 illustrates another embodiment of a parameter compensated physiological monitor 400 (FIG. 4). A parameter compensated multiple wavelength monitor 600 has inputs from a sensor 610 and an external pH monitor 650. The sensor 610 has multiple wavelength emitters 620 and a site temperature element 630. Multiple wavelengths may be achieved, for example, by utilizing multiple LEDs each manufactured for a specific wavelength according to the number of wavelengths desired. Alternatively, one or more LEDs having drive current dependent wavelengths may be utilized, where the drive current is controlled to shift between multiple wavelengths. The site temperature element 630 provides a site temperature parameter input to the sensor front-end 664. In one embodiment, the site temperature element 630 is a thermistor located on the sensor 610 proximate the emitters 620 or proximate the detector 640. The detector 640 provides a multiple wavelength signal output that is combined with a site temperature output to a sensor front-end 664. An instrument interface 665 is adapted to input pH readings from the pH monitor 650. The sensor drivers 662 provide multiplexed activation of the multiple emitters 620 as determined by the controller 669. The signal processor 666 accepts outputs from the sensor front-end 664 and the instrument interface 665. In addition, the signal processor 666 computes an SpO2 measurement from the detector signal along with a sensor parameter, such as Hct for example, utilizing the multiple wavelength signal from the detector 640. Further, the signal processor 666 derives a compensated SpO2 measurement from the site temperature, pH, and Hct parameters, as described with respect to FIGS. 7-13, below. The compensated SpO2 measurement is then displayed 667, 668 in a manner similar to that described above.
  • As shown in FIG. 6, a pulse oximetry sensor 610 may be improved for use in conjunction with a parameter compensated pulse oximeter by increasing the number of wavelengths projected by the emitters 620, which allows the resolution of more than two blood constituents, as described above. Further, the sensor 610 may be improved by adding the capability to measure various parameters, such as site temperature. Alternatively, as shown in FIG. 5, pulse oximeter performance can be improved at reduced costs by utilizing simple sensors in conjunction with other instrumentation and/or manual inputs to provide additional input parameters.
  • The sensor 610 may also have an information element (not shown) that describes information regarding the sensor. In one embodiment, the information element provides the monitor 660 with information regarding available wavelengths for the emitters 620 and/or information regarding the temperature element 630, such as the resistance-temperature characteristics of a thermistor. An information element is described in U.S. Pat. No. 6,011,986 entitled “Manual And Automatic Probe Calibration,” assigned to Masimo Corporation, Irvine, Calif. and incorporated by referenced herein.
  • Parameter Compensation Signal Processing
  • FIG. 7 illustrates a compensation relationship function 700 that the signal processor 440 (FIG. 4) performs. The compensation relationship 700 has a spectral characteristic input or inputs 702 and parameter inputs 704 and generates a compensated physiological measurement output 708. The spectral characteristic 702 is derived from the primary input 412 (FIG. 4), the parameters 704 are received from the interfaces 410-430 (FIG. 4), and the physiological measurement 708 is provided at the signal processor output 442 (FIG. 4), as described above. FIGS. 8-14, below, illustrate various embodiments of the compensation relationship 700. FIGS. 8-9 illustrate a compensation relationship incorporating parameter modification of baseline calibration data. FIGS. 10A-B illustrate parameter correction of an uncompensated physiological measurement. FIGS. 11-12 illustrate parameter incorporation into multidimensional calibration data. FIGS. 13A-B illustrate parameter modification of sensor wavelength and selection of wavelength-dependent calibration data. FIG. 14 illustrates parameter modification of physiological measurement algorithms.
  • FIG. 8A illustrates a compensation relationship 800 having a look-up table 810, baseline calibration data 830 and a calibration data modification function 820. The compensation relationship 800 has a spectral characteristic input 802, parameter inputs 804 and a physiological measurement output 808, as described above. The calibration data modification 820 advantageously responds to the parameters 804 to select, modify, derive or otherwise determine from the baseline calibration data 830 a calibration data input 822 to the look-up table 810. The look-up table 810 uses the calibration data 822 to determine the physiological measurement 808 corresponding to the spectral characteristic 802. The calibration data 822 may also be responsive to feedback of the physiological measurement 808. The baseline calibration data 830 may be determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of the physiological measurement and associated parameters. Also, all or part of the look-up table 810, calibration data modification 820 and baseline calibration data 830 may be replaced by or combined with a mathematical formula or algorithm, theoretically or experimentally derived, that is used to compute calibration data or used to directly compute the physiological measurement from the spectral characteristic and parameter inputs.
  • FIGS. 8B-C describe one pulse oximeter embodiment of the compensation relationship 800 (FIG. 8A). As shown in FIG. 8B, the blood gas compensation relationship 851 has an RD/IR input 802 and generates an SpO2 output 808 utilizing baseline calibration data 880 that is modified according to an input value of arterial oxygen saturation SpO2. The compensation relationship 851 has a calibration data modification function 871 that provides modified calibration data 872 to a look-up table 860, as described with respect to FIG. 8A, above.
  • As shown in FIG. 8C, the calibration data modification 871 has comparison 891 and sensitivity filter 893 functions that input to modification rules 895 that operate on the baseline calibration data 882 to provide modified calibration data 872. The comparison 891 determines a difference between SpO 2 804 and SpO 2 808 so that the compensation relationship 871 can function to reduce the discrepancy between blood gas measurement and pulse oximeter measurements of oxygen saturation.
  • The responsiveness to blood gas measurements is determined by a sensitivity filter 893 and sensitivity adjustment 809. So as to reduce over-sensitivity of a calibration data to blood gas measurements, calibration data modification may require multiple blood gas input values over a range of saturation values and/or consistency within a tolerance range before calibration data is modified. Also, calibration data modification can be less sensitive to more frequently occurring normal saturation values and more sensitive to the less frequently occurring low saturation values. Hence, the sensitivity filter 893 may have a blood gas input 804 so that responsiveness varies with the range of blood gas sample values. Further, calibration data may be piecewise modified according to ranges of saturation values, so that an entire range of calibration data is not affected by blood gas measurements that are limited to a certain range of saturation values.
  • TABLE 1, below, illustrates one embodiment of the modification rules 895. Saturation Range is a range of blood gas measurements and a corresponding portion of the calibration curve to be replaced or modified. Number of Samples is the number of blood gas measurements required within the corresponding Saturation Range before a calibration curve modification or replacement is made. Sample Tolerance is the deviation allowed between measured SpO2 and measured SpO2 for a particular blood gas measurement to be considered. For example, the saturation ranges may be in 5% increments, i.e. 100-95%, 95-90%, etc. The number of samples may be, say, 4 for saturation measurements above 75% and 1 for saturation measurements below 75%. The sample tolerance may be SpO2-SpO2=±1%.
    TABLE 1
    Calibration Data Modification Rules
    SATURATION RANGE NUMBER OF SAMPLE
    (%) SAMPLES TOLERANCE
    100-x1 n1 Δ1
    x1-x2 n2 Δ2
    . . .
    . . .
    . . .
    xi-50 ni Δi
  • Depending on the embodiment, the modification rules 895 may operate on the baseline calibration data to select one of a family of calibration curves, determine the direction and amount of shift in a calibration curve, modify the shape of a calibration curve, rotate a calibration curve around a selected point on the curve, specify one or more points from which a calibration curve may be derived, or a combination of these actions. In this manner a pulse oximeter may be calibrated on site for individual patients, for improved accuracy as compared with total reliance on empirical calibration data derived from many individuals. Calibration curve modification in response to blood gas measurements is described in further detail with respect to FIGS. 9A-D, below.
  • FIGS. 9A-D illustrate calibration data modification utilizing a Bezier curve. In its most common form, a Bezier curve is a simple cubic equation defined by four points including the end points and two control points, as is well-known in the art. As shown in FIG. 9A a calibration curve 910, such as described with respect to FIG. 3, above can be approximated as a Bezier curve with an associated first control point 920 and second control point 930.
  • As shown in FIG. 9B, the initial Bezier curve 910 (FIG. 9A) can be modified in response to a blood gas measurement providing a first calibration point 940 at a relatively high saturation value. In particular, a modified calibration curve 911 can be derived in response to the first calibration point 940 by repositioning the first and second control points 920-930 so that the modified calibration curve 911 more closely approximates the first calibration point 940 than the original calibration curve 910 without significantly altering the original calibration curve 910 (FIG. 9A) within saturation ranges away from the first calibration point 940.
  • As shown in FIG. 9C, the modified calibration curve 911 (FIG. 9B) can be modified in response to a second calibration point 950 at a relatively low saturation value. In particular, a modified calibration curve 912 can be derived in response to the first and second calibration points 940-950 by again repositioning the first and second control points 920-930 so that the modified calibration curve 912 more closely approximates the calibration points 940-950.
  • As shown in FIG. 9D, the modified calibration curve 912 (FIG. 9C) can be modified yet again in response to a third calibration point 960. In particular, a modified calibration curve 913 can be derived in response to the three calibration points 940-960 by further repositioning the control points 920-930 so that the modified calibration curve 913 more closely approximates the calibration points 940-960.
  • Multiple calibration points may be accommodated by curve-fitting algorithms well-known in the art, such as a least-means-squared computation of the error between the modified calibration curve and the calibration points, as one example. Other polynomials curves may be used to derive modified calibration curves, and two or more sections of Bezier curves or other polynomial curves can be used to represent a modified calibration curve.
  • FIG. 10A illustrates a measurement correction compensation relationship 1000 having a look-up table 1010, calibration data 1020, and a measurement correction function 1030. The compensation relationship 1000 differs from the compensation relationship 800 (FIG. 8A) described above in that, an uncompensated physiological measurement 1018 is calculated and corrected to yield a compensated physiological measurement 1008. This contrasts with a compensated physiological measurement being directly derived from a spectral characteristic and parameters, as described with respect to FIG. 8A, above.
  • FIG. 10B illustrates an upgrade compensation relationship 1001 embodiment of the compensation relationship 1000 (FIG. 10A) described above. The compensation relationship 1001 advantageously upgrades the uncompensated oxygen saturation measurement of a conventional pulse oximeter. In particular, the look-up table 1010 and calibration curve 1020 may be as described with respect to FIGS. 2-3, above. In one embodiment, the measurement correction 1031 is a look-up table having a correction data set as input, where the correction data set is determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of oxygen saturation and associated parameters. In another embodiment, the measurement correction 1031 is a mathematical formula or algorithm that directly computes a compensated SpO2 output from uncompensated SpO2 and parameter inputs. In yet another embodiment, the measurement correction is a combination of look-up table and mathematical formula or algorithm. The compensation parameters may be, for example, one or more of T, pH, Hct, HbCO, MetHb, to name a few.
  • FIG. 11 illustrates a multidimensional calibration function 1100 having a look-up table 1110 and associated multidimensional calibration data 1120. The look-up table 1110 has a spectral characteristic input 1112, such as RD/IR, and one or more compensation parameters 1114, such as T, pH, Hct, HbCO, MetHb, etc., as described with respect to FIG. 7, above. In response to the spectral characteristic 1112 and parameter 1114 inputs, the look-up table 1110 provides a physiological measurement output 1118, such as a compensated oxygen saturation value, also as described with respect to FIG. 7, above. The look-up table 1110 may function as a calibration surface 1210 (FIG. 12) in a somewhat analogous manner to the calibration curve described with respect to FIG. 3, above. The multidimensional calibration data 1120 may be determined by statistical regression of experimental measurements obtained from human volunteers and calibrated measurements of the physiological measurement and associated parameters. Also, the look-up table 1110 and calibration data 1120 may be replaced by or combined with a mathematical formula or algorithm, theoretically or experimentally derived, used to directly compute a physiological measurement from spectral characteristic and parameter inputs.
  • FIG. 12 is a three-dimensional graph 1200 illustrating the look-up table calibration function described with respect to FIG. 11, above. The graph 1200 has an x-axis 1201 representing derived spectral characteristic values, a y-axis 1203 representing a parameter value, and a z-axis 1205 representing physiological measurement values that result from locating a position on the surface 1210 corresponding to a combination of spectral characteristic and parameter values. The three-dimensional graph 1200 may be extended to accommodate multiple parameters, so as to create a calibration surface in multidimensional hyperspace.
  • In one advantageous embodiment, a blood gas measurement of HbCO and/or MetHb is manually entered into a pulse oximeter and utilized to generate a compensated value of SpO2. As described above, conventional pulse oximetry utilizes two wavelengths, assuming that Hb and HbO2 are the only significant absorbers. However, HbCO and MetHb may also be significant absorbers at RD and IR wavelengths. The presence of significant concentrations of HbCO and MetHb have different effects on a conventional pulse oximeter estimate of oxygen saturation. HbO2 and HbCO have similar extinctions at the RD wavelength, as do MetHb and Hb. At the IR wavelength, HbCO is relatively transparent whereas MetHb has greater extinction than the other hemoglobins. The two wavelength assumption tends to lump HbO2 and HbCO together, i.e. HbCO is counted as an oxygen carrying form of hemoglobin, causing a conventional pulse oximeter to overestimate oxygen saturation. As MetHb increases, RD/IR tends to unity and SpO2 tends to a constant (e.g. 85%) regardless of oxygen saturation. A manually entered value of HbCO and or MetHb is used as a parameter in conjunction with the functions described above with respect to any of FIGS. 7-11, so as to distinguish these hemoglobin species from HbO2 and Hb, providing a more accurate, HbCO and/or MetHb compensated, value of SpO2.
  • FIG. 13A illustrates a wavelength compensation relationship 1300 having a look-up table 1310, wavelength-dependent calibration data 1320, and a wavelength determination function 1330. The wavelength compensation relationship 1300 advantageously changes sensor wavelength to generate a wavelength-compensated physiological measurement output 1308. The look-up table 1310 has a spectral characteristic input 1302 and generates a physiological measurement output 1308 utilizing the wavelength-dependent calibration data 1320. The wavelength determination function 1330 has parameter 1304 inputs and, in one embodiment, a feedback input of the physiological measurement 1308, and provides a sensor wavelength selection output 1338. The wavelength selection output 1338 provides a calibration data 1320 input for selecting wavelength-dependent portions of the calibration data 1320. As above, the look-up table 1310 and/or the calibration data 1320 may be replaced by or combined with mathematical formulas or algorithms. The wavelength control output 1338 is a feedback path to a controller 669 (FIG. 6) and/or drivers 662 (FIG. 6), for example, so as to modify the wavelength of a multiple-wavelength sensor 610 (FIG. 6). FIG. 13B, below, illustrates one advantageous pulse oximeter embodiment of the wavelength compensation relationship 1300.
  • FIG. 13B illustrates an oxygen saturation dependent wavelength compensation relationship 1301 having a null parameter input 1304 (FIG. 13A), i.e. no parameter is used, and a wavelength control output 1338 that is dependent on the SpO2 output 1308. In particular, the wavelength determination function 1330 has SpO 2 1308 as input and generates a wavelength selection output 1338, accordingly. For example, the wavelength selection output 1338 determines particular red and IR wavelengths to be used for conventional pulse oximetry measurements and a corresponding one of a family of wavelength dependent calibration curves 1320. In this manner, sensor wavelength can be dynamically adjusted based upon saturation levels, e.g. a first red and/or IR wavelength may be used in low saturation conditions and a second red and/or IR wavelength may be used in normal saturation conditions.
  • FIG. 14 illustrates parameter compensation of pulse rate measurements. In this pulse oximetry embodiment, the compensation relationship 1400 includes a pulse rate calculation 1410 having a plethysmograph input 1402 and providing a pulse rate measurement output 1408. The pulse rate calculation 1410 also has one or more parameter inputs 1404, such as a manual input indicating the presence of an implant device, such as an IABP or a pacemaker, or the presence of an arrhythmia. The parameter input is used to alter the pulse rate calculation 1410 so as to derive a more accurate pulse rate measurement 1408. For example, the criteria for determining a physiologically acceptable pulse on the plethysmograph input 1402, such as aspects of the pulse shape, may be altered according to the parameter input 1404. Pulse rate calculations are described in U.S. Pat. No. 6,463,311 entitled “Plethysmograph Pulse Recognition Processor,” which is assigned to Masimo Corporation, Irvine, Calif. and incorporated by reference herein.
  • A parameter compensated physiological monitor has been disclosed in detail in connection with various embodiments. These embodiments are disclosed by way of examples only and are not to limit the scope of the claims that follow. One of ordinary skill in the art will appreciate many variations and modifications.

Claims (24)

1. A physiological monitor comprising:
an optical sensor providing a first sensor signal responsive to a plurality of wavelengths of optical radiation after attenuation by pulsatile blood flowing within a tissue site of a patient;
a non-optical sensor providing a second sensor signal corresponding to the patient;
a processor configured to derive a spectral characteristic of the tissue site from the first sensor signal;
calibration data relating the spectral characteristic to a blood gas parameter of the patient; and
a correction applied to the calibration data in response to the second sensor signal.
2. The physiological monitor according to claim 1:
wherein the non-optical sensor has a temperature sensing element, and
wherein the second sensor signal is responsive to a tissue site temperature.
3. The physiological monitor according to claim 2:
wherein the calibration data defines a Bezier curve having end points and corresponding control points, and
wherein the correction repositions the control points so as to generate a modified calibration curve.
4. A physiological monitor comprising:
a primary input responsive to optical properties of a tissue site of a patient;
a characteristic of the tissue site derived from the primary input;
a calibration curve relating the characteristic to a blood gas parameter for the patient;
a blood gas value derived from the primary input and the calibration curve;
a secondary input responsive to non-optical properties corresponding to the patient; and
a compensation applied to at least one of the calibration curve and the blood gas value in response to the secondary input so as to derive a compensated blood gas value that is more accurate than the blood gas value.
5. The physiological monitor according to claim 4 wherein the secondary input provides a measure of the patient's blood pH.
6. The physiological monitor according to claim 5 wherein the secondary input is a blood pH value manually entered through a user interface.
7. The physiological monitor according to claim 5 wherein the secondary input is an output from a blood pH monitor having a sensor in contact with the patient.
8. A physiological monitoring method comprising:
generating an optical measurement at a tissue site having pulsatile blood flow;
defining calibration data relating the optical measurement to a blood gas parameter corresponding to the pulsatile blood flow;
calculating the optical measurement and the calibration data with a processor so as to generate a blood gas value corresponding to the blood gas parameter;
providing a non-optical measurement corresponding to the tissue site; and
correcting at least one of the calibration data and the blood gas value according to the non-optical measurement.
9. The physiological monitoring method according to claim 8:
wherein generating comprises attaching an optical sensor to the tissue site; and
wherein providing comprises integrating a non-optical sensor element into the optical sensor so as to make the non-optical measurement.
10. The physiological monitoring method according to claim 9 wherein integrating comprises positioning a thermistor within the optical sensor so as to take a temperature measurement of the tissue site.
11. The physiological monitoring method according to claim 8 wherein providing comprises attaching a non-optical sensor to the tissue site.
12. The physiological monitoring method according to claim 11 wherein providing further comprises taking a temperature measurement of the tissue site.
13. The physiological monitoring method according to claim 8 wherein providing comprises manually inputting into the processor via a user interface a non-optical measurement value corresponding to the tissue site.
14. The physiological monitoring method according to claim 13 wherein manually inputting comprises entering a tissue temperature value on a keypad that is in communications with the processor.
15. A physiological monitoring method comprising:
generating a non-invasive measurement at a tissue site of a patient;
defining calibration data relating the non-invasive measurement to a blood gas parameter;
calculating with a processor a blood gas value corresponding to the non-invasive measurement;
providing an invasive measurement of the patient;
compensating the blood gas value according to the invasive measurement.
16. The physiological monitoring method according to claim 15 wherein providing comprises measuring a blood pH value for the patient.
17. The physiological monitoring method according to claim 16 wherein measuring comprises manually entering the blood pH value via a user interface into the processor.
18. The physiological monitoring method according to claim 16 wherein measuring comprises outputting the blood pH value from a pH monitor via an instrument interface to the processor.
19. A physiological monitor comprising:
an optical sensor means for providing a tissue site spectral characteristic for a patient;
a non-optical input means for providing a compensation parameter for the patient;
a calibration means for relating the spectral characteristic to an uncompensated blood gas parameter; and
a correction means responsive to the compensation parameter for generating a compensated blood gas parameter.
20. The physiological monitor according to claim 19 further comprising a processor for applying the correction means to the calibration means.
21. The physiological monitor according to claim 19 further comprising a processor for applying the correction means to the uncompensated blood gas parameter.
22. The physiological monitor according to claim 19 further comprising a user interface means for manually entering a value for the compensation parameter into the processor.
23. The physiological monitor according to claim 19 further comprising an instrument interface means for entering the compensation parameter from an external monitor into the processor.
24. The physiological monitor according to claim 19:
wherein the calibration means comprises a Bezier curve; and
wherein the correction means comprises a control means for altering the shape of the Bezier curve.
US11/604,499 2002-09-25 2006-11-27 Parameter compensated physiological monitor Abandoned US20070073127A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/604,499 US20070073127A1 (en) 2002-09-25 2006-11-27 Parameter compensated physiological monitor

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41349402P 2002-09-25 2002-09-25
US42663802P 2002-11-16 2002-11-16
US10/671,179 US7274955B2 (en) 2002-09-25 2003-09-25 Parameter compensated pulse oximeter
US10/714,526 US7142901B2 (en) 2002-09-25 2003-11-14 Parameter compensated physiological monitor
US11/604,499 US20070073127A1 (en) 2002-09-25 2006-11-27 Parameter compensated physiological monitor

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US10/671,179 Continuation-In-Part US7274955B2 (en) 2002-09-25 2003-09-25 Parameter compensated pulse oximeter
US10/714,526 Continuation US7142901B2 (en) 2002-09-25 2003-11-14 Parameter compensated physiological monitor

Publications (1)

Publication Number Publication Date
US20070073127A1 true US20070073127A1 (en) 2007-03-29

Family

ID=37895027

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/714,526 Active 2024-09-15 US7142901B2 (en) 2002-09-25 2003-11-14 Parameter compensated physiological monitor
US11/604,499 Abandoned US20070073127A1 (en) 2002-09-25 2006-11-27 Parameter compensated physiological monitor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/714,526 Active 2024-09-15 US7142901B2 (en) 2002-09-25 2003-11-14 Parameter compensated physiological monitor

Country Status (1)

Country Link
US (2) US7142901B2 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060253016A1 (en) * 2001-03-16 2006-11-09 R Baker Clark Jr Systems and methods to assess one or more body fluid metrics
US20080221412A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc Method and apparatus for spectroscopic tissue analyte measurement
US20080221410A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc Method for identification of sensor site by local skin spectrum data
US20080220512A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc Tunable laser-based spectroscopy system for non-invasively measuring body water content
US20080221416A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc System and method for detection of macular degeneration using spectrophotometry
US20080221409A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc System and method for controlling tissue treatment
US20090247852A1 (en) * 2008-03-31 2009-10-01 Nellcor Puritan Bennett Llc System and method for facilitating sensor and monitor communication
US8265724B2 (en) 2007-03-09 2012-09-11 Nellcor Puritan Bennett Llc Cancellation of light shunting
US8280469B2 (en) 2007-03-09 2012-10-02 Nellcor Puritan Bennett Llc Method for detection of aberrant tissue spectra
US8391941B2 (en) 2009-07-17 2013-03-05 Covidien Lp System and method for memory switching for multiple configuration medical sensor
US8417310B2 (en) 2009-08-10 2013-04-09 Covidien Lp Digital switching in multi-site sensor
WO2013077808A1 (en) * 2011-11-25 2013-05-30 Nitto Denko Corporation A method of obtaining a correction factor and a calibration device facilitating performance of said method
US9066660B2 (en) 2009-09-29 2015-06-30 Nellcor Puritan Bennett Ireland Systems and methods for high-pass filtering a photoplethysmograph signal
US10159412B2 (en) 2010-12-01 2018-12-25 Cercacor Laboratories, Inc. Handheld processing device including medical applications for minimally and non invasive glucose measurements
WO2021146407A1 (en) * 2020-01-15 2021-07-22 MX3 Diagnostics, Inc. Assessment of biomarker concentration in a fluid
US11690566B2 (en) 2017-11-21 2023-07-04 MX3 Diagnostics, Inc. Saliva testing system
US11703436B2 (en) 2020-01-30 2023-07-18 MX3 Diagnostics, Inc. Biological fluid sample assessment
US11701036B2 (en) 2019-07-10 2023-07-18 MX3 Diagnostics, Inc. Saliva test strip and method

Families Citing this family (352)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9702434A (en) 1991-03-07 1998-05-31 Masimo Corp Signal processing apparatus.
US5490505A (en) 1991-03-07 1996-02-13 Masimo Corporation Signal processing apparatus
US5638818A (en) 1991-03-21 1997-06-17 Masimo Corporation Low noise optical probe
EP1905352B1 (en) 1994-10-07 2014-07-16 Masimo Corporation Signal processing method
US8019400B2 (en) 1994-10-07 2011-09-13 Masimo Corporation Signal processing apparatus
US5758644A (en) 1995-06-07 1998-06-02 Masimo Corporation Manual and automatic probe calibration
US6229856B1 (en) 1997-04-14 2001-05-08 Masimo Corporation Method and apparatus for demodulating signals in a pulse oximetry system
US6002952A (en) 1997-04-14 1999-12-14 Masimo Corporation Signal processing apparatus and method
JP2002516689A (en) 1998-06-03 2002-06-11 マシモ・コーポレイション Stereo pulse oximeter
US7245953B1 (en) 1999-04-12 2007-07-17 Masimo Corporation Reusable pulse oximeter probe and disposable bandage apparatii
USRE41912E1 (en) 1998-10-15 2010-11-02 Masimo Corporation Reusable pulse oximeter probe and disposable bandage apparatus
US6721585B1 (en) 1998-10-15 2004-04-13 Sensidyne, Inc. Universal modular pulse oximeter probe for use with reusable and disposable patient attachment devices
US6463311B1 (en) 1998-12-30 2002-10-08 Masimo Corporation Plethysmograph pulse recognition processor
US6684090B2 (en) 1999-01-07 2004-01-27 Masimo Corporation Pulse oximetry data confidence indicator
US20020140675A1 (en) 1999-01-25 2002-10-03 Ali Ammar Al System and method for altering a display mode based on a gravity-responsive sensor
US6360114B1 (en) 1999-03-25 2002-03-19 Masimo Corporation Pulse oximeter probe-off detector
US6675031B1 (en) 1999-04-14 2004-01-06 Mallinckrodt Inc. Method and circuit for indicating quality and accuracy of physiological measurements
US6515273B2 (en) 1999-08-26 2003-02-04 Masimo Corporation System for indicating the expiration of the useful operating life of a pulse oximetry sensor
US6377829B1 (en) 1999-12-09 2002-04-23 Masimo Corporation Resposable pulse oximetry sensor
US6950687B2 (en) 1999-12-09 2005-09-27 Masimo Corporation Isolation and communication element for a resposable pulse oximetry sensor
US6430525B1 (en) 2000-06-05 2002-08-06 Masimo Corporation Variable mode averager
ATE549969T1 (en) 2000-08-18 2012-04-15 Masimo Corp PULSE OXIMETER WITH DUAL MODE
US6640116B2 (en) 2000-08-18 2003-10-28 Masimo Corporation Optical spectroscopy pathlength measurement system
US6850787B2 (en) 2001-06-29 2005-02-01 Masimo Laboratories, Inc. Signal component processor
US6697658B2 (en) 2001-07-02 2004-02-24 Masimo Corporation Low power pulse oximeter
US7355512B1 (en) 2002-01-24 2008-04-08 Masimo Corporation Parallel alarm processor
US6882874B2 (en) * 2002-02-15 2005-04-19 Datex-Ohmeda, Inc. Compensation of human variability in pulse oximetry
US6850788B2 (en) 2002-03-25 2005-02-01 Masimo Corporation Physiological measurement communications adapter
US7190986B1 (en) 2002-10-18 2007-03-13 Nellcor Puritan Bennett Inc. Non-adhesive oximeter sensor for sensitive skin
US6970792B1 (en) 2002-12-04 2005-11-29 Masimo Laboratories, Inc. Systems and methods for determining blood oxygen saturation values using complex number encoding
US7919713B2 (en) 2007-04-16 2011-04-05 Masimo Corporation Low noise oximetry cable including conductive cords
US6920345B2 (en) 2003-01-24 2005-07-19 Masimo Corporation Optical sensor including disposable and reusable elements
US7003338B2 (en) 2003-07-08 2006-02-21 Masimo Corporation Method and apparatus for reducing coupling between signals
US7500950B2 (en) 2003-07-25 2009-03-10 Masimo Corporation Multipurpose sensor port
US7254431B2 (en) 2003-08-28 2007-08-07 Masimo Corporation Physiological parameter tracking system
US7483729B2 (en) 2003-11-05 2009-01-27 Masimo Corporation Pulse oximeter access apparatus and method
US7438683B2 (en) 2004-03-04 2008-10-21 Masimo Corporation Application identification sensor
JP2007527776A (en) 2004-03-08 2007-10-04 マシモ・コーポレイション Physiological parameter system
CA2464029A1 (en) 2004-04-08 2005-10-08 Valery Telfort Non-invasive ventilation monitor
US7343186B2 (en) 2004-07-07 2008-03-11 Masimo Laboratories, Inc. Multi-wavelength physiological monitor
US9341565B2 (en) 2004-07-07 2016-05-17 Masimo Corporation Multiple-wavelength physiological monitor
US7937128B2 (en) 2004-07-09 2011-05-03 Masimo Corporation Cyanotic infant sensor
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
US20060189871A1 (en) 2005-02-18 2006-08-24 Ammar Al-Ali Portable patient monitor
US8224411B2 (en) 2005-03-01 2012-07-17 Masimo Laboratories, Inc. Noninvasive multi-parameter patient monitor
CA2604653A1 (en) 2005-04-13 2006-10-19 Glucolight Corporation Method for data reduction and calibration of an oct-based blood glucose monitor
US7657294B2 (en) 2005-08-08 2010-02-02 Nellcor Puritan Bennett Llc Compliant diaphragm medical sensor and technique for using the same
US7657295B2 (en) 2005-08-08 2010-02-02 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7590439B2 (en) 2005-08-08 2009-09-15 Nellcor Puritan Bennett Llc Bi-stable medical sensor and technique for using the same
US20070060808A1 (en) 2005-09-12 2007-03-15 Carine Hoarau Medical sensor for reducing motion artifacts and technique for using the same
US7840246B1 (en) * 2005-09-20 2010-11-23 Pacesetter, Inc. Implantable self-calibrating optical sensors
US8092379B2 (en) 2005-09-29 2012-01-10 Nellcor Puritan Bennett Llc Method and system for determining when to reposition a physiological sensor
US7904130B2 (en) 2005-09-29 2011-03-08 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7899510B2 (en) 2005-09-29 2011-03-01 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7869850B2 (en) 2005-09-29 2011-01-11 Nellcor Puritan Bennett Llc Medical sensor for reducing motion artifacts and technique for using the same
US8233954B2 (en) 2005-09-30 2012-07-31 Nellcor Puritan Bennett Llc Mucosal sensor for the assessment of tissue and blood constituents and technique for using the same
US7555327B2 (en) 2005-09-30 2009-06-30 Nellcor Puritan Bennett Llc Folding medical sensor and technique for using the same
US7486979B2 (en) 2005-09-30 2009-02-03 Nellcor Puritan Bennett Llc Optically aligned pulse oximetry sensor and technique for using the same
US7483731B2 (en) 2005-09-30 2009-01-27 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US7881762B2 (en) 2005-09-30 2011-02-01 Nellcor Puritan Bennett Llc Clip-style medical sensor and technique for using the same
US8062221B2 (en) 2005-09-30 2011-11-22 Nellcor Puritan Bennett Llc Sensor for tissue gas detection and technique for using the same
US7962188B2 (en) 2005-10-14 2011-06-14 Masimo Corporation Robust alarm system
JP5049289B2 (en) 2005-11-29 2012-10-17 マシモ コーポレイション Optical sensor including disposable and reusable elements
US7990382B2 (en) 2006-01-03 2011-08-02 Masimo Corporation Virtual display
US8182443B1 (en) 2006-01-17 2012-05-22 Masimo Corporation Drug administration controller
US8219172B2 (en) 2006-03-17 2012-07-10 Glt Acquisition Corp. System and method for creating a stable optical interface
US8073518B2 (en) 2006-05-02 2011-12-06 Nellcor Puritan Bennett Llc Clip-style medical sensor and technique for using the same
US9176141B2 (en) 2006-05-15 2015-11-03 Cercacor Laboratories, Inc. Physiological monitor calibration system
US8998809B2 (en) 2006-05-15 2015-04-07 Cercacor Laboratories, Inc. Systems and methods for calibrating minimally invasive and non-invasive physiological sensor devices
US7941199B2 (en) 2006-05-15 2011-05-10 Masimo Laboratories, Inc. Sepsis monitor
US8028701B2 (en) 2006-05-31 2011-10-04 Masimo Corporation Respiratory monitoring
US10188348B2 (en) 2006-06-05 2019-01-29 Masimo Corporation Parameter upgrade system
US20080039735A1 (en) * 2006-06-06 2008-02-14 Hickerson Barry L Respiratory monitor display
US8145288B2 (en) 2006-08-22 2012-03-27 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US8118620B2 (en) 2007-10-12 2012-02-21 Masimo Corporation Connector assembly with reduced unshielded area
US8219170B2 (en) 2006-09-20 2012-07-10 Nellcor Puritan Bennett Llc System and method for practicing spectrophotometry using light emitting nanostructure devices
US8315683B2 (en) 2006-09-20 2012-11-20 Masimo Corporation Duo connector patient cable
USD609193S1 (en) 2007-10-12 2010-02-02 Masimo Corporation Connector assembly
USD614305S1 (en) 2008-02-29 2010-04-20 Masimo Corporation Connector assembly
US8457707B2 (en) 2006-09-20 2013-06-04 Masimo Corporation Congenital heart disease monitor
US8175671B2 (en) * 2006-09-22 2012-05-08 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US8396527B2 (en) 2006-09-22 2013-03-12 Covidien Lp Medical sensor for reducing signal artifacts and technique for using the same
US8190225B2 (en) 2006-09-22 2012-05-29 Nellcor Puritan Bennett Llc Medical sensor for reducing signal artifacts and technique for using the same
US9161696B2 (en) 2006-09-22 2015-10-20 Masimo Corporation Modular patient monitor
US8840549B2 (en) 2006-09-22 2014-09-23 Masimo Corporation Modular patient monitor
US7869849B2 (en) 2006-09-26 2011-01-11 Nellcor Puritan Bennett Llc Opaque, electrically nonconductive region on a medical sensor
US7574245B2 (en) 2006-09-27 2009-08-11 Nellcor Puritan Bennett Llc Flexible medical sensor enclosure
US7796403B2 (en) 2006-09-28 2010-09-14 Nellcor Puritan Bennett Llc Means for mechanical registration and mechanical-electrical coupling of a faraday shield to a photodetector and an electrical circuit
US7890153B2 (en) 2006-09-28 2011-02-15 Nellcor Puritan Bennett Llc System and method for mitigating interference in pulse oximetry
US7476131B2 (en) 2006-09-29 2009-01-13 Nellcor Puritan Bennett Llc Device for reducing crosstalk
US8175667B2 (en) 2006-09-29 2012-05-08 Nellcor Puritan Bennett Llc Symmetric LED array for pulse oximetry
US7684842B2 (en) 2006-09-29 2010-03-23 Nellcor Puritan Bennett Llc System and method for preventing sensor misuse
US7680522B2 (en) 2006-09-29 2010-03-16 Nellcor Puritan Bennett Llc Method and apparatus for detecting misapplied sensors
US8068891B2 (en) 2006-09-29 2011-11-29 Nellcor Puritan Bennett Llc Symmetric LED array for pulse oximetry
US9861305B1 (en) 2006-10-12 2018-01-09 Masimo Corporation Method and apparatus for calibration to reduce coupling between signals in a measurement system
US8265723B1 (en) 2006-10-12 2012-09-11 Cercacor Laboratories, Inc. Oximeter probe off indicator defining probe off space
US7880626B2 (en) 2006-10-12 2011-02-01 Masimo Corporation System and method for monitoring the life of a physiological sensor
US8280473B2 (en) 2006-10-12 2012-10-02 Masino Corporation, Inc. Perfusion index smoother
US9192329B2 (en) 2006-10-12 2015-11-24 Masimo Corporation Variable mode pulse indicator
US8255026B1 (en) 2006-10-12 2012-08-28 Masimo Corporation, Inc. Patient monitor capable of monitoring the quality of attached probes and accessories
US8600467B2 (en) 2006-11-29 2013-12-03 Cercacor Laboratories, Inc. Optical sensor including disposable and reusable elements
US8414499B2 (en) 2006-12-09 2013-04-09 Masimo Corporation Plethysmograph variability processor
US8852094B2 (en) 2006-12-22 2014-10-07 Masimo Corporation Physiological parameter system
US7791155B2 (en) 2006-12-22 2010-09-07 Masimo Laboratories, Inc. Detector shield
US8652060B2 (en) 2007-01-20 2014-02-18 Masimo Corporation Perfusion trend indicator
US7894869B2 (en) 2007-03-09 2011-02-22 Nellcor Puritan Bennett Llc Multiple configuration medical sensor and technique for using the same
EP2476369B1 (en) 2007-03-27 2014-10-01 Masimo Laboratories, Inc. Multiple wavelength optical sensor
US8374665B2 (en) 2007-04-21 2013-02-12 Cercacor Laboratories, Inc. Tissue profile wellness monitor
US8764671B2 (en) 2007-06-28 2014-07-01 Masimo Corporation Disposable active pulse sensor
US8048040B2 (en) 2007-09-13 2011-11-01 Masimo Corporation Fluid titration system
US8310336B2 (en) 2008-10-10 2012-11-13 Masimo Corporation Systems and methods for storing, analyzing, retrieving and displaying streaming medical data
US8355766B2 (en) 2007-10-12 2013-01-15 Masimo Corporation Ceramic emitter substrate
EP2208158A2 (en) 2007-10-12 2010-07-21 Masimo Corporation Systems and methods for storing, analyzing, and retrieving medical data
US8346328B2 (en) 2007-12-21 2013-01-01 Covidien Lp Medical sensor and technique for using the same
US8352004B2 (en) 2007-12-21 2013-01-08 Covidien Lp Medical sensor and technique for using the same
US8366613B2 (en) 2007-12-26 2013-02-05 Covidien Lp LED drive circuit for pulse oximetry and method for using same
US8577434B2 (en) 2007-12-27 2013-11-05 Covidien Lp Coaxial LED light sources
US8452364B2 (en) 2007-12-28 2013-05-28 Covidien LLP System and method for attaching a sensor to a patient's skin
US8442608B2 (en) 2007-12-28 2013-05-14 Covidien Lp System and method for estimating physiological parameters by deconvolving artifacts
US8199007B2 (en) 2007-12-31 2012-06-12 Nellcor Puritan Bennett Llc Flex circuit snap track for a biometric sensor
US8070508B2 (en) 2007-12-31 2011-12-06 Nellcor Puritan Bennett Llc Method and apparatus for aligning and securing a cable strain relief
US8092993B2 (en) 2007-12-31 2012-01-10 Nellcor Puritan Bennett Llc Hydrogel thin film for use as a biosensor
US8897850B2 (en) 2007-12-31 2014-11-25 Covidien Lp Sensor with integrated living hinge and spring
WO2009111542A2 (en) 2008-03-04 2009-09-11 Glucolight Corporation Methods and systems for analyte level estimation in optical coherence tomography
US8437822B2 (en) 2008-03-28 2013-05-07 Covidien Lp System and method for estimating blood analyte concentration
US8112375B2 (en) 2008-03-31 2012-02-07 Nellcor Puritan Bennett Llc Wavelength selection and outlier detection in reduced rank linear models
WO2009134724A1 (en) 2008-05-02 2009-11-05 Masimo Corporation Monitor configuration system
US9107625B2 (en) 2008-05-05 2015-08-18 Masimo Corporation Pulse oximetry system with electrical decoupling circuitry
US8071935B2 (en) 2008-06-30 2011-12-06 Nellcor Puritan Bennett Llc Optical detector with an overmolded faraday shield
US7880884B2 (en) 2008-06-30 2011-02-01 Nellcor Puritan Bennett Llc System and method for coating and shielding electronic sensor components
US7887345B2 (en) 2008-06-30 2011-02-15 Nellcor Puritan Bennett Llc Single use connector for pulse oximetry sensors
US8437825B2 (en) 2008-07-03 2013-05-07 Cercacor Laboratories, Inc. Contoured protrusion for improving spectroscopic measurement of blood constituents
USD621516S1 (en) 2008-08-25 2010-08-10 Masimo Laboratories, Inc. Patient monitoring sensor
US8203438B2 (en) 2008-07-29 2012-06-19 Masimo Corporation Alarm suspend system
US8630691B2 (en) 2008-08-04 2014-01-14 Cercacor Laboratories, Inc. Multi-stream sensor front ends for noninvasive measurement of blood constituents
SE532941C2 (en) 2008-09-15 2010-05-18 Phasein Ab Gas sampling line for breathing gases
US8911377B2 (en) 2008-09-15 2014-12-16 Masimo Corporation Patient monitor including multi-parameter graphical display
US8364220B2 (en) 2008-09-25 2013-01-29 Covidien Lp Medical sensor and technique for using the same
US9314168B2 (en) 2008-09-30 2016-04-19 Nellcor Puritan Bennett Ireland Detecting sleep events using localized blood pressure changes
US8914088B2 (en) 2008-09-30 2014-12-16 Covidien Lp Medical sensor and technique for using the same
US8423112B2 (en) 2008-09-30 2013-04-16 Covidien Lp Medical sensor and technique for using the same
US8417309B2 (en) 2008-09-30 2013-04-09 Covidien Lp Medical sensor
US8401602B2 (en) 2008-10-13 2013-03-19 Masimo Corporation Secondary-emitter sensor position indicator
US8346330B2 (en) 2008-10-13 2013-01-01 Masimo Corporation Reflection-detector sensor position indicator
US8771204B2 (en) 2008-12-30 2014-07-08 Masimo Corporation Acoustic sensor assembly
US8588880B2 (en) 2009-02-16 2013-11-19 Masimo Corporation Ear sensor
US10007758B2 (en) 2009-03-04 2018-06-26 Masimo Corporation Medical monitoring system
US10032002B2 (en) 2009-03-04 2018-07-24 Masimo Corporation Medical monitoring system
WO2010102069A2 (en) 2009-03-04 2010-09-10 Masimo Corporation Medical monitoring system
US9323894B2 (en) 2011-08-19 2016-04-26 Masimo Corporation Health care sanitation monitoring system
US8388353B2 (en) 2009-03-11 2013-03-05 Cercacor Laboratories, Inc. Magnetic connector
US8452366B2 (en) 2009-03-16 2013-05-28 Covidien Lp Medical monitoring device with flexible circuitry
US8897847B2 (en) 2009-03-23 2014-11-25 Masimo Corporation Digit gauge for noninvasive optical sensor
US8221319B2 (en) 2009-03-25 2012-07-17 Nellcor Puritan Bennett Llc Medical device for assessing intravascular blood volume and technique for using the same
US8509869B2 (en) 2009-05-15 2013-08-13 Covidien Lp Method and apparatus for detecting and analyzing variations in a physiologic parameter
WO2010135373A1 (en) 2009-05-19 2010-11-25 Masimo Corporation Disposable components for reusable physiological sensor
US8571619B2 (en) 2009-05-20 2013-10-29 Masimo Corporation Hemoglobin display and patient treatment
US8634891B2 (en) 2009-05-20 2014-01-21 Covidien Lp Method and system for self regulation of sensor component contact pressure
US8418524B2 (en) 2009-06-12 2013-04-16 Masimo Corporation Non-invasive sensor calibration device
US8311601B2 (en) 2009-06-30 2012-11-13 Nellcor Puritan Bennett Llc Reflectance and/or transmissive pulse oximeter
US9010634B2 (en) 2009-06-30 2015-04-21 Covidien Lp System and method for linking patient data to a patient and providing sensor quality assurance
US8670811B2 (en) 2009-06-30 2014-03-11 Masimo Corporation Pulse oximetry system for adjusting medical ventilation
US8505821B2 (en) 2009-06-30 2013-08-13 Covidien Lp System and method for providing sensor quality assurance
US8471713B2 (en) 2009-07-24 2013-06-25 Cercacor Laboratories, Inc. Interference detector for patient monitor
US8473020B2 (en) 2009-07-29 2013-06-25 Cercacor Laboratories, Inc. Non-invasive physiological sensor cover
US8428675B2 (en) 2009-08-19 2013-04-23 Covidien Lp Nanofiber adhesives used in medical devices
US8688183B2 (en) 2009-09-03 2014-04-01 Ceracor Laboratories, Inc. Emitter driver for noninvasive patient monitor
US20110172498A1 (en) 2009-09-14 2011-07-14 Olsen Gregory A Spot check monitor credit system
US9579039B2 (en) 2011-01-10 2017-02-28 Masimo Corporation Non-invasive intravascular volume index monitor
DE112010003689T5 (en) 2009-09-17 2013-01-17 Marcelo Lamego Improved analyte monitoring using one or more accelerometers
US20110137297A1 (en) 2009-09-17 2011-06-09 Kiani Massi Joe E Pharmacological management system
US8571618B1 (en) 2009-09-28 2013-10-29 Cercacor Laboratories, Inc. Adaptive calibration system for spectrophotometric measurements
US20110082711A1 (en) 2009-10-06 2011-04-07 Masimo Laboratories, Inc. Personal digital assistant or organizer for monitoring glucose levels
US8870792B2 (en) 2009-10-15 2014-10-28 Masimo Corporation Physiological acoustic monitoring system
US8790268B2 (en) 2009-10-15 2014-07-29 Masimo Corporation Bidirectional physiological information display
US9106038B2 (en) 2009-10-15 2015-08-11 Masimo Corporation Pulse oximetry system with low noise cable hub
US9066680B1 (en) 2009-10-15 2015-06-30 Masimo Corporation System for determining confidence in respiratory rate measurements
US10463340B2 (en) 2009-10-15 2019-11-05 Masimo Corporation Acoustic respiratory monitoring systems and methods
WO2011047216A2 (en) 2009-10-15 2011-04-21 Masimo Corporation Physiological acoustic monitoring system
US8702627B2 (en) 2009-10-15 2014-04-22 Masimo Corporation Acoustic respiratory monitoring sensor having multiple sensing elements
US9724016B1 (en) 2009-10-16 2017-08-08 Masimo Corp. Respiration processor
US9839381B1 (en) 2009-11-24 2017-12-12 Cercacor Laboratories, Inc. Physiological measurement system with automatic wavelength adjustment
GB2487882B (en) 2009-12-04 2017-03-29 Masimo Corp Calibration for multi-stage physiological monitors
US9153112B1 (en) 2009-12-21 2015-10-06 Masimo Corporation Modular patient monitor
GB2490817A (en) 2010-01-19 2012-11-14 Masimo Corp Wellness analysis system
US9724024B2 (en) 2010-03-01 2017-08-08 Masimo Corporation Adaptive alarm system
EP2544591B1 (en) 2010-03-08 2021-07-21 Masimo Corporation Reprocessing of a physiological sensor
US9307928B1 (en) 2010-03-30 2016-04-12 Masimo Corporation Plethysmographic respiration processor
US8712494B1 (en) 2010-05-03 2014-04-29 Masimo Corporation Reflective non-invasive sensor
US9138180B1 (en) 2010-05-03 2015-09-22 Masimo Corporation Sensor adapter cable
US7884933B1 (en) 2010-05-05 2011-02-08 Revolutionary Business Concepts, Inc. Apparatus and method for determining analyte concentrations
US8666468B1 (en) 2010-05-06 2014-03-04 Masimo Corporation Patient monitor for determining microcirculation state
US9326712B1 (en) 2010-06-02 2016-05-03 Masimo Corporation Opticoustic sensor
US8740792B1 (en) 2010-07-12 2014-06-03 Masimo Corporation Patient monitor capable of accounting for environmental conditions
US9408542B1 (en) 2010-07-22 2016-08-09 Masimo Corporation Non-invasive blood pressure measurement system
US9649054B2 (en) 2010-08-26 2017-05-16 Cercacor Laboratories, Inc. Blood pressure measurement method
EP2621333B1 (en) 2010-09-28 2015-07-29 Masimo Corporation Depth of consciousness monitor including oximeter
US9775545B2 (en) 2010-09-28 2017-10-03 Masimo Corporation Magnetic electrical connector for patient monitors
US9211095B1 (en) 2010-10-13 2015-12-15 Masimo Corporation Physiological measurement logic engine
US8723677B1 (en) 2010-10-20 2014-05-13 Masimo Corporation Patient safety system with automatically adjusting bed
WO2012109671A1 (en) 2011-02-13 2012-08-16 Masimo Corporation Medical characterization system
US9066666B2 (en) 2011-02-25 2015-06-30 Cercacor Laboratories, Inc. Patient monitor for monitoring microcirculation
US8830449B1 (en) 2011-04-18 2014-09-09 Cercacor Laboratories, Inc. Blood analysis system
US9095316B2 (en) 2011-04-20 2015-08-04 Masimo Corporation System for generating alarms based on alarm patterns
US9622692B2 (en) 2011-05-16 2017-04-18 Masimo Corporation Personal health device
US9986919B2 (en) 2011-06-21 2018-06-05 Masimo Corporation Patient monitoring system
US9532722B2 (en) 2011-06-21 2017-01-03 Masimo Corporation Patient monitoring system
US9245668B1 (en) 2011-06-29 2016-01-26 Cercacor Laboratories, Inc. Low noise cable providing communication between electronic sensor components and patient monitor
US11439329B2 (en) 2011-07-13 2022-09-13 Masimo Corporation Multiple measurement mode in a physiological sensor
US9192351B1 (en) 2011-07-22 2015-11-24 Masimo Corporation Acoustic respiratory monitoring sensor with probe-off detection
US8755872B1 (en) 2011-07-28 2014-06-17 Masimo Corporation Patient monitoring system for indicating an abnormal condition
US9782077B2 (en) 2011-08-17 2017-10-10 Masimo Corporation Modulated physiological sensor
US9943269B2 (en) 2011-10-13 2018-04-17 Masimo Corporation System for displaying medical monitoring data
US9808188B1 (en) 2011-10-13 2017-11-07 Masimo Corporation Robust fractional saturation determination
EP2766834B1 (en) 2011-10-13 2022-04-20 Masimo Corporation Medical monitoring hub
US9778079B1 (en) 2011-10-27 2017-10-03 Masimo Corporation Physiological monitor gauge panel
US9445759B1 (en) 2011-12-22 2016-09-20 Cercacor Laboratories, Inc. Blood glucose calibration system
US11172890B2 (en) 2012-01-04 2021-11-16 Masimo Corporation Automated condition screening and detection
US9392945B2 (en) 2012-01-04 2016-07-19 Masimo Corporation Automated CCHD screening and detection
US10307111B2 (en) 2012-02-09 2019-06-04 Masimo Corporation Patient position detection system
US10149616B2 (en) 2012-02-09 2018-12-11 Masimo Corporation Wireless patient monitoring device
US9480435B2 (en) 2012-02-09 2016-11-01 Masimo Corporation Configurable patient monitoring system
US20130317368A1 (en) 2012-03-12 2013-11-28 Ivwatch, Llc System for Mitigating the Effects of Tissue Blood Volume Changes to Aid in Diagnosing Infiltration or Extravasation in Animalia Tissue
US9195385B2 (en) 2012-03-25 2015-11-24 Masimo Corporation Physiological monitor touchscreen interface
WO2013158791A2 (en) 2012-04-17 2013-10-24 Masimo Corporation Hypersaturation index
US10542903B2 (en) 2012-06-07 2020-01-28 Masimo Corporation Depth of consciousness monitor
US9697928B2 (en) 2012-08-01 2017-07-04 Masimo Corporation Automated assembly sensor cable
US10827961B1 (en) 2012-08-29 2020-11-10 Masimo Corporation Physiological measurement calibration
US9877650B2 (en) 2012-09-20 2018-01-30 Masimo Corporation Physiological monitor with mobile computing device connectivity
US9749232B2 (en) 2012-09-20 2017-08-29 Masimo Corporation Intelligent medical network edge router
US9955937B2 (en) 2012-09-20 2018-05-01 Masimo Corporation Acoustic patient sensor coupler
US9717458B2 (en) 2012-10-20 2017-08-01 Masimo Corporation Magnetic-flap optical sensor
US9560996B2 (en) 2012-10-30 2017-02-07 Masimo Corporation Universal medical system
US9787568B2 (en) 2012-11-05 2017-10-10 Cercacor Laboratories, Inc. Physiological test credit method
US9750461B1 (en) 2013-01-02 2017-09-05 Masimo Corporation Acoustic respiratory monitoring sensor with probe-off detection
US9724025B1 (en) 2013-01-16 2017-08-08 Masimo Corporation Active-pulse blood analysis system
US9750442B2 (en) 2013-03-09 2017-09-05 Masimo Corporation Physiological status monitor
US10441181B1 (en) 2013-03-13 2019-10-15 Masimo Corporation Acoustic pulse and respiration monitoring system
WO2014164139A1 (en) 2013-03-13 2014-10-09 Masimo Corporation Systems and methods for monitoring a patient health network
US9936917B2 (en) 2013-03-14 2018-04-10 Masimo Laboratories, Inc. Patient monitor placement indicator
US9474474B2 (en) 2013-03-14 2016-10-25 Masimo Corporation Patient monitor as a minimally invasive glucometer
US9986952B2 (en) 2013-03-14 2018-06-05 Masimo Corporation Heart sound simulator
US10456038B2 (en) 2013-03-15 2019-10-29 Cercacor Laboratories, Inc. Cloud-based physiological monitoring system
CN105228517A (en) * 2013-04-05 2016-01-06 日东电工股份有限公司 Optical measurement is used to measure method and the device of the SpO2 of testee
US9891079B2 (en) 2013-07-17 2018-02-13 Masimo Corporation Pulser with double-bearing position encoder for non-invasive physiological monitoring
WO2015020911A2 (en) 2013-08-05 2015-02-12 Cercacor Laboratories, Inc. Blood pressure monitor with valve-chamber assembly
WO2015038683A2 (en) 2013-09-12 2015-03-19 Cercacor Laboratories, Inc. Medical device management system
US20150099950A1 (en) 2013-10-07 2015-04-09 Masimo Corporation Regional oximetry sensor
US11147518B1 (en) 2013-10-07 2021-10-19 Masimo Corporation Regional oximetry signal processor
US10832818B2 (en) 2013-10-11 2020-11-10 Masimo Corporation Alarm notification system
US10828007B1 (en) 2013-10-11 2020-11-10 Masimo Corporation Acoustic sensor with attachment portion
US10279247B2 (en) 2013-12-13 2019-05-07 Masimo Corporation Avatar-incentive healthcare therapy
US10086138B1 (en) 2014-01-28 2018-10-02 Masimo Corporation Autonomous drug delivery system
US11259745B2 (en) 2014-01-28 2022-03-01 Masimo Corporation Autonomous drug delivery system
JP6364792B2 (en) * 2014-01-31 2018-08-01 セイコーエプソン株式会社 Biological information processing method, biological information processing apparatus, computer system, and wearable device
US10532174B2 (en) 2014-02-21 2020-01-14 Masimo Corporation Assistive capnography device
US9924897B1 (en) 2014-06-12 2018-03-27 Masimo Corporation Heated reprocessing of physiological sensors
US10123729B2 (en) 2014-06-13 2018-11-13 Nanthealth, Inc. Alarm fatigue management systems and methods
US10231670B2 (en) 2014-06-19 2019-03-19 Masimo Corporation Proximity sensor in pulse oximeter
US10111591B2 (en) 2014-08-26 2018-10-30 Nanthealth, Inc. Real-time monitoring systems and methods in a healthcare environment
WO2016036985A1 (en) 2014-09-04 2016-03-10 Masimo Corportion Total hemoglobin index system
US10383520B2 (en) 2014-09-18 2019-08-20 Masimo Semiconductor, Inc. Enhanced visible near-infrared photodiode and non-invasive physiological sensor
US10154815B2 (en) 2014-10-07 2018-12-18 Masimo Corporation Modular physiological sensors
KR102575058B1 (en) 2015-01-23 2023-09-05 마시모 스웨덴 에이비 Nasal/Oral Cannula Systems and Manufacturing
USD755392S1 (en) 2015-02-06 2016-05-03 Masimo Corporation Pulse oximetry sensor
CA2974832C (en) 2015-02-06 2023-05-23 Masimo Corporation Connector assembly with pogo pins for use with medical sensors
US10568553B2 (en) 2015-02-06 2020-02-25 Masimo Corporation Soft boot pulse oximetry sensor
EP3766419B1 (en) 2015-02-06 2024-01-10 Masimo Corporation Fold flex circuit for lnop
US10524738B2 (en) 2015-05-04 2020-01-07 Cercacor Laboratories, Inc. Noninvasive sensor system with visual infographic display
US11653862B2 (en) 2015-05-22 2023-05-23 Cercacor Laboratories, Inc. Non-invasive optical physiological differential pathlength sensor
US10952638B2 (en) * 2015-06-12 2021-03-23 ChroniSense Medical Ltd. System and method for monitoring respiratory rate and oxygen saturation
US10448871B2 (en) 2015-07-02 2019-10-22 Masimo Corporation Advanced pulse oximetry sensor
US10750981B2 (en) * 2015-09-25 2020-08-25 Sanmina Corporation System and method for health monitoring including a remote device
US10991135B2 (en) 2015-08-11 2021-04-27 Masimo Corporation Medical monitoring analysis and replay including indicia responsive to light attenuated by body tissue
US10448844B2 (en) 2015-08-31 2019-10-22 Masimo Corporation Systems and methods for patient fall detection
US11504066B1 (en) 2015-09-04 2022-11-22 Cercacor Laboratories, Inc. Low-noise sensor system
US11679579B2 (en) 2015-12-17 2023-06-20 Masimo Corporation Varnish-coated release liner
US10537285B2 (en) 2016-03-04 2020-01-21 Masimo Corporation Nose sensor
US10993662B2 (en) 2016-03-04 2021-05-04 Masimo Corporation Nose sensor
US11191484B2 (en) 2016-04-29 2021-12-07 Masimo Corporation Optical sensor tape
US10608817B2 (en) 2016-07-06 2020-03-31 Masimo Corporation Secure and zero knowledge data sharing for cloud applications
US10617302B2 (en) 2016-07-07 2020-04-14 Masimo Corporation Wearable pulse oximeter and respiration monitor
US11076777B2 (en) 2016-10-13 2021-08-03 Masimo Corporation Systems and methods for monitoring orientation to reduce pressure ulcer formation
US11504058B1 (en) 2016-12-02 2022-11-22 Masimo Corporation Multi-site noninvasive measurement of a physiological parameter
US10750984B2 (en) 2016-12-22 2020-08-25 Cercacor Laboratories, Inc. Methods and devices for detecting intensity of light with translucent detector
US10721785B2 (en) 2017-01-18 2020-07-21 Masimo Corporation Patient-worn wireless physiological sensor with pairing functionality
US11213819B2 (en) 2017-01-30 2022-01-04 Noavaran Payesh Ani Salamat (AZSense) Integrated patient monitor system
US11086609B2 (en) 2017-02-24 2021-08-10 Masimo Corporation Medical monitoring hub
US10388120B2 (en) 2017-02-24 2019-08-20 Masimo Corporation Localized projection of audible noises in medical settings
US11024064B2 (en) 2017-02-24 2021-06-01 Masimo Corporation Augmented reality system for displaying patient data
US10327713B2 (en) 2017-02-24 2019-06-25 Masimo Corporation Modular multi-parameter patient monitoring device
WO2018156648A1 (en) 2017-02-24 2018-08-30 Masimo Corporation Managing dynamic licenses for physiological parameters in a patient monitoring environment
WO2018156804A1 (en) 2017-02-24 2018-08-30 Masimo Corporation System for displaying medical monitoring data
EP3592231A1 (en) 2017-03-10 2020-01-15 Masimo Corporation Pneumonia screener
WO2018194992A1 (en) 2017-04-18 2018-10-25 Masimo Corporation Nose sensor
US10918281B2 (en) 2017-04-26 2021-02-16 Masimo Corporation Medical monitoring device having multiple configurations
USD835285S1 (en) 2017-04-28 2018-12-04 Masimo Corporation Medical monitoring device
USD835284S1 (en) 2017-04-28 2018-12-04 Masimo Corporation Medical monitoring device
WO2018201078A1 (en) 2017-04-28 2018-11-01 Masimo Corporation Spot check measurement system
USD835283S1 (en) 2017-04-28 2018-12-04 Masimo Corporation Medical monitoring device
USD835282S1 (en) 2017-04-28 2018-12-04 Masimo Corporation Medical monitoring device
KR102559598B1 (en) 2017-05-08 2023-07-25 마시모 코오퍼레이션 A system for pairing a medical system to a network controller using a dongle
US11026604B2 (en) 2017-07-13 2021-06-08 Cercacor Laboratories, Inc. Medical monitoring device for harmonizing physiological measurements
USD890708S1 (en) 2017-08-15 2020-07-21 Masimo Corporation Connector
CN116805771A (en) 2017-08-15 2023-09-26 梅西莫股份有限公司 Waterproof connector for noninvasive patient monitor
USD906970S1 (en) 2017-08-15 2021-01-05 Masimo Corporation Connector
EP4039177A1 (en) 2017-10-19 2022-08-10 Masimo Corporation Display arrangement for medical monitoring system
USD925597S1 (en) 2017-10-31 2021-07-20 Masimo Corporation Display screen or portion thereof with graphical user interface
US10987066B2 (en) 2017-10-31 2021-04-27 Masimo Corporation System for displaying oxygen state indications
US11766198B2 (en) 2018-02-02 2023-09-26 Cercacor Laboratories, Inc. Limb-worn patient monitoring device
EP3782165A1 (en) 2018-04-19 2021-02-24 Masimo Corporation Mobile patient alarm display
WO2019209915A1 (en) 2018-04-24 2019-10-31 Cercacor Laboratories, Inc. Easy insert finger sensor for transmission based spectroscopy sensor
WO2019236759A1 (en) 2018-06-06 2019-12-12 Masimo Corporation Opioid overdose monitoring
US10779098B2 (en) 2018-07-10 2020-09-15 Masimo Corporation Patient monitor alarm speaker analyzer
US11872156B2 (en) 2018-08-22 2024-01-16 Masimo Corporation Core body temperature measurement
USD917564S1 (en) 2018-10-11 2021-04-27 Masimo Corporation Display screen or portion thereof with graphical user interface
USD998630S1 (en) 2018-10-11 2023-09-12 Masimo Corporation Display screen or portion thereof with a graphical user interface
USD999246S1 (en) 2018-10-11 2023-09-19 Masimo Corporation Display screen or portion thereof with a graphical user interface
USD916135S1 (en) 2018-10-11 2021-04-13 Masimo Corporation Display screen or portion thereof with a graphical user interface
US11406286B2 (en) 2018-10-11 2022-08-09 Masimo Corporation Patient monitoring device with improved user interface
EP4258492A3 (en) 2018-10-11 2023-12-13 Masimo Corporation Patient connector assembly with vertical detents
USD917550S1 (en) 2018-10-11 2021-04-27 Masimo Corporation Display screen or portion thereof with a graphical user interface
USD998631S1 (en) 2018-10-11 2023-09-12 Masimo Corporation Display screen or portion thereof with a graphical user interface
US11389093B2 (en) 2018-10-11 2022-07-19 Masimo Corporation Low noise oximetry cable
USD897098S1 (en) 2018-10-12 2020-09-29 Masimo Corporation Card holder set
US11464410B2 (en) 2018-10-12 2022-10-11 Masimo Corporation Medical systems and methods
KR20210084490A (en) 2018-10-12 2021-07-07 마시모 코오퍼레이션 System for transmission of sensor data using dual communication protocol
US11684296B2 (en) 2018-12-21 2023-06-27 Cercacor Laboratories, Inc. Noninvasive physiological sensor
US20210022628A1 (en) 2019-04-17 2021-01-28 Masimo Corporation Patient monitoring systems, devices, and methods
USD985498S1 (en) 2019-08-16 2023-05-09 Masimo Corporation Connector
USD919094S1 (en) 2019-08-16 2021-05-11 Masimo Corporation Blood pressure device
USD919100S1 (en) 2019-08-16 2021-05-11 Masimo Corporation Holder for a patient monitor
USD921202S1 (en) 2019-08-16 2021-06-01 Masimo Corporation Holder for a blood pressure device
USD917704S1 (en) 2019-08-16 2021-04-27 Masimo Corporation Patient monitor
US11832940B2 (en) 2019-08-27 2023-12-05 Cercacor Laboratories, Inc. Non-invasive medical monitoring device for blood analyte measurements
USD927699S1 (en) 2019-10-18 2021-08-10 Masimo Corporation Electrode pad
WO2021077019A1 (en) 2019-10-18 2021-04-22 Masimo Corporation Display layout and interactive objects for patient monitoring
US11879960B2 (en) 2020-02-13 2024-01-23 Masimo Corporation System and method for monitoring clinical activities
WO2021163447A1 (en) 2020-02-13 2021-08-19 Masimo Corporation System and method for monitoring clinical activities
US20210290072A1 (en) 2020-03-20 2021-09-23 Masimo Corporation Wearable device for noninvasive body temperature measurement
USD933232S1 (en) 2020-05-11 2021-10-12 Masimo Corporation Blood pressure monitor
USD979516S1 (en) 2020-05-11 2023-02-28 Masimo Corporation Connector
CN111671436A (en) * 2020-05-21 2020-09-18 东南大学 Temperature-compensated photoacoustic noninvasive hemoglobin detection device and detection method
USD974193S1 (en) 2020-07-27 2023-01-03 Masimo Corporation Wearable temperature measurement device
USD980091S1 (en) 2020-07-27 2023-03-07 Masimo Corporation Wearable temperature measurement device
US11771350B1 (en) * 2020-09-11 2023-10-03 Apple Inc. System and method for robust pulse oximetry using asymmetric distance-dependent calibration
USD946598S1 (en) 2020-09-30 2022-03-22 Masimo Corporation Display screen or portion thereof with graphical user interface
USD946596S1 (en) 2020-09-30 2022-03-22 Masimo Corporation Display screen or portion thereof with graphical user interface
USD946597S1 (en) 2020-09-30 2022-03-22 Masimo Corporation Display screen or portion thereof with graphical user interface
USD997365S1 (en) 2021-06-24 2023-08-29 Masimo Corporation Physiological nose sensor
USD1000975S1 (en) 2021-09-22 2023-10-10 Masimo Corporation Wearable temperature measurement device

Citations (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892101A (en) * 1986-08-18 1990-01-09 Physio-Control Corporation Method and apparatus for offsetting baseline portion of oximeter signal
US5005576A (en) * 1988-04-09 1991-04-09 Hewlett-Packard Company Optical probe
US5041187A (en) * 1988-04-29 1991-08-20 Thor Technology Corporation Oximeter sensor assembly with integral cable and method of forming the same
US5190039A (en) * 1989-12-08 1993-03-02 Hitachi, Ltd. Apparatus and method for monitoring body organs
US5337744A (en) * 1993-07-14 1994-08-16 Masimo Corporation Low noise finger cot probe
US5431170A (en) * 1990-05-26 1995-07-11 Mathews; Geoffrey R. Pulse responsive device
USD361840S (en) * 1994-04-21 1995-08-29 Gary Savage Stethoscope head
US5482036A (en) * 1991-03-07 1996-01-09 Masimo Corporation Signal processing apparatus and method
US5490505A (en) * 1991-03-07 1996-02-13 Masimo Corporation Signal processing apparatus
US5494043A (en) * 1993-05-04 1996-02-27 Vital Insite, Inc. Arterial sensor
US5533511A (en) * 1994-01-05 1996-07-09 Vital Insite, Incorporated Apparatus and method for noninvasive blood pressure measurement
US5590649A (en) * 1994-04-15 1997-01-07 Vital Insite, Inc. Apparatus and method for measuring an induced perturbation to determine blood pressure
US5602924A (en) * 1992-12-07 1997-02-11 Theratechnologies Inc. Electronic stethescope
US5632272A (en) * 1991-03-07 1997-05-27 Masimo Corporation Signal processing apparatus
US5638816A (en) * 1995-06-07 1997-06-17 Masimo Corporation Active pulse blood constituent monitoring
US5638818A (en) * 1991-03-21 1997-06-17 Masimo Corporation Low noise optical probe
US5645440A (en) * 1995-10-16 1997-07-08 Masimo Corporation Patient cable connector
US5725480A (en) * 1996-03-06 1998-03-10 Abbott Laboratories Non-invasive calibration and categorization of individuals for subsequent non-invasive detection of biological compounds
USD393830S (en) * 1995-10-16 1998-04-28 Masimo Corporation Patient cable connector
US5743262A (en) * 1995-06-07 1998-04-28 Masimo Corporation Blood glucose monitoring system
US5760910A (en) * 1995-06-07 1998-06-02 Masimo Corporation Optical filter for spectroscopic measurement and method of producing the optical filter
US5758644A (en) * 1995-06-07 1998-06-02 Masimo Corporation Manual and automatic probe calibration
US5785659A (en) * 1994-04-15 1998-07-28 Vital Insite, Inc. Automatically activated blood pressure measurement device
US5791347A (en) * 1994-04-15 1998-08-11 Vital Insite, Inc. Motion insensitive pulse detector
US5890929A (en) * 1996-06-19 1999-04-06 Masimo Corporation Shielded medical connector
US5904654A (en) * 1995-10-20 1999-05-18 Vital Insite, Inc. Exciter-detector unit for measuring physiological parameters
US5919134A (en) * 1997-04-14 1999-07-06 Masimo Corp. Method and apparatus for demodulating signals in a pulse oximetry system
US6027452A (en) * 1996-06-26 2000-02-22 Vital Insite, Inc. Rapid non-invasive blood pressure measuring device
US6045509A (en) * 1994-04-15 2000-04-04 Vital Insite, Inc. Apparatus and method for measuring an induced perturbation to determine a physiological parameter
US6067462A (en) * 1997-04-14 2000-05-23 Masimo Corporation Signal processing apparatus and method
US6104938A (en) * 1996-06-12 2000-08-15 Instrumentarium Oy Procedure, apparatus and detector for the determination of fractional oxygen saturation
US6184521B1 (en) * 1998-01-06 2001-02-06 Masimo Corporation Photodiode detector with integrated noise shielding
US6229856B1 (en) * 1997-04-14 2001-05-08 Masimo Corporation Method and apparatus for demodulating signals in a pulse oximetry system
US6343224B1 (en) * 1998-10-15 2002-01-29 Sensidyne, Inc. Reusable pulse oximeter probe and disposable bandage apparatus
US6349228B1 (en) * 1998-02-11 2002-02-19 Masimo Corporation Pulse oximetry sensor adapter
US6356774B1 (en) * 1998-09-29 2002-03-12 Mallinckrodt, Inc. Oximeter sensor with encoded temperature characteristic
US6360114B1 (en) * 1999-03-25 2002-03-19 Masimo Corporation Pulse oximeter probe-off detector
US6371921B1 (en) * 1994-04-15 2002-04-16 Masimo Corporation System and method of determining whether to recalibrate a blood pressure monitor
US6377829B1 (en) * 1999-12-09 2002-04-23 Masimo Corporation Resposable pulse oximetry sensor
US6388240B2 (en) * 1999-08-26 2002-05-14 Masimo Corporation Shielded optical probe and method having a longevity indication
US6421549B1 (en) * 1999-07-14 2002-07-16 Providence Health System-Oregon Adaptive calibration pulsed oximetry method and device
US6515273B2 (en) * 1999-08-26 2003-02-04 Masimo Corporation System for indicating the expiration of the useful operating life of a pulse oximetry sensor
US6519487B1 (en) * 1998-10-15 2003-02-11 Sensidyne, Inc. Reusable pulse oximeter probe and disposable bandage apparatus
US6526300B1 (en) * 1999-06-18 2003-02-25 Masimo Corporation Pulse oximeter probe-off detection system
US6525386B1 (en) * 1998-03-10 2003-02-25 Masimo Corporation Non-protruding optoelectronic lens
US6542764B1 (en) * 1999-12-01 2003-04-01 Masimo Corporation Pulse oximeter monitor for expressing the urgency of the patient's condition
US6541756B2 (en) * 1991-03-21 2003-04-01 Masimo Corporation Shielded optical probe having an electrical connector
US6584336B1 (en) * 1999-01-25 2003-06-24 Masimo Corporation Universal/upgrading pulse oximeter
US6595316B2 (en) * 2001-07-18 2003-07-22 Andromed, Inc. Tension-adjustable mechanism for stethoscope earpieces
US6684091B2 (en) * 1998-10-15 2004-01-27 Sensidyne, Inc. Reusable pulse oximeter probe and disposable bandage method
US6684090B2 (en) * 1999-01-07 2004-01-27 Masimo Corporation Pulse oximetry data confidence indicator
US6697656B1 (en) * 2000-06-27 2004-02-24 Masimo Corporation Pulse oximetry sensor compatible with multiple pulse oximetry systems
US6697658B2 (en) * 2001-07-02 2004-02-24 Masimo Corporation Low power pulse oximeter
US6714804B2 (en) * 1998-06-03 2004-03-30 Masimo Corporation Stereo pulse oximeter
US6721585B1 (en) * 1998-10-15 2004-04-13 Sensidyne, Inc. Universal modular pulse oximeter probe for use with reusable and disposable patient attachment devices
US6745060B2 (en) * 1991-03-07 2004-06-01 Masimo Corporation Signal processing apparatus
US6760607B2 (en) * 2000-12-29 2004-07-06 Masimo Corporation Ribbon cable substrate pulse oximetry sensor
US6850788B2 (en) * 2002-03-25 2005-02-01 Masimo Corporation Physiological measurement communications adapter
US6850787B2 (en) * 2001-06-29 2005-02-01 Masimo Laboratories, Inc. Signal component processor
US6920345B2 (en) * 2003-01-24 2005-07-19 Masimo Corporation Optical sensor including disposable and reusable elements
US6985764B2 (en) * 2001-05-03 2006-01-10 Masimo Corporation Flex circuit shielded optical sensor
US6999904B2 (en) * 2000-06-05 2006-02-14 Masimo Corporation Variable indication estimator
US7003338B2 (en) * 2003-07-08 2006-02-21 Masimo Corporation Method and apparatus for reducing coupling between signals
US7015451B2 (en) * 2002-01-25 2006-03-21 Masimo Corporation Power supply rail controller
US7027849B2 (en) * 2002-11-22 2006-04-11 Masimo Laboratories, Inc. Blood parameter measurement system
US7030749B2 (en) * 2002-01-24 2006-04-18 Masimo Corporation Parallel measurement alarm processor
US7044918B2 (en) * 1998-12-30 2006-05-16 Masimo Corporation Plethysmograph pulse recognition processor

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5163438A (en) * 1988-11-14 1992-11-17 Paramed Technology Incorporated Method and apparatus for continuously and noninvasively measuring the blood pressure of a patient
US4960128A (en) * 1988-11-14 1990-10-02 Paramed Technology Incorporated Method and apparatus for continuously and non-invasively measuring the blood pressure of a patient
US5372136A (en) * 1990-10-06 1994-12-13 Noninvasive Medical Technology Corporation System and method for noninvasive hematocrit monitoring
US5452717A (en) * 1993-07-14 1995-09-26 Masimo Corporation Finger-cot probe
DE69737031T2 (en) 1996-07-19 2007-04-26 Daedalus I, Llc DEVICE FOR NON-INVASIVE DETERMINATION OF BLOOD PARAMETERS
US5842979A (en) * 1997-02-14 1998-12-01 Ohmeda Inc. Method and apparatus for improved photoplethysmographic monitoring of oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin
US5997343A (en) * 1998-03-19 1999-12-07 Masimo Corporation Patient cable sensor switch
US6165005A (en) * 1998-03-19 2000-12-26 Masimo Corporation Patient cable sensor switch
US6285896B1 (en) * 1998-07-13 2001-09-04 Masimo Corporation Fetal pulse oximetry sensor
US6606511B1 (en) * 1999-01-07 2003-08-12 Masimo Corporation Pulse oximetry pulse indicator
US6770028B1 (en) 1999-01-25 2004-08-03 Masimo Corporation Dual-mode pulse oximeter
US6658276B2 (en) * 1999-01-25 2003-12-02 Masimo Corporation Pulse oximeter user interface
US6671531B2 (en) * 1999-12-09 2003-12-30 Masimo Corporation Sensor wrap including foldable applicator
US6152754A (en) * 1999-12-21 2000-11-28 Masimo Corporation Circuit board based cable connector
US6470199B1 (en) * 2000-06-21 2002-10-22 Masimo Corporation Elastic sock for positioning an optical probe
US6640116B2 (en) * 2000-08-18 2003-10-28 Masimo Corporation Optical spectroscopy pathlength measurement system

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892101A (en) * 1986-08-18 1990-01-09 Physio-Control Corporation Method and apparatus for offsetting baseline portion of oximeter signal
US5005576A (en) * 1988-04-09 1991-04-09 Hewlett-Packard Company Optical probe
US5041187A (en) * 1988-04-29 1991-08-20 Thor Technology Corporation Oximeter sensor assembly with integral cable and method of forming the same
US5190039A (en) * 1989-12-08 1993-03-02 Hitachi, Ltd. Apparatus and method for monitoring body organs
US5431170A (en) * 1990-05-26 1995-07-11 Mathews; Geoffrey R. Pulse responsive device
US5490505A (en) * 1991-03-07 1996-02-13 Masimo Corporation Signal processing apparatus
US6745060B2 (en) * 1991-03-07 2004-06-01 Masimo Corporation Signal processing apparatus
US5482036A (en) * 1991-03-07 1996-01-09 Masimo Corporation Signal processing apparatus and method
US6263222B1 (en) * 1991-03-07 2001-07-17 Masimo Corporation Signal processing apparatus
US6081735A (en) * 1991-03-07 2000-06-27 Masimo Corporation Signal processing apparatus
US5769785A (en) * 1991-03-07 1998-06-23 Masimo Corporation Signal processing apparatus and method
USRE38492E1 (en) * 1991-03-07 2004-04-06 Masimo Corporation Signal processing apparatus and method
US6206830B1 (en) * 1991-03-07 2001-03-27 Masimo Corporation Signal processing apparatus and method
US5632272A (en) * 1991-03-07 1997-05-27 Masimo Corporation Signal processing apparatus
USRE38476E1 (en) * 1991-03-07 2004-03-30 Masimo Corporation Signal processing apparatus
US6236872B1 (en) * 1991-03-07 2001-05-22 Masimo Corporation Signal processing apparatus
US6036642A (en) * 1991-03-07 2000-03-14 Masimo Corporation Signal processing apparatus and method
US6256523B1 (en) * 1991-03-21 2001-07-03 Masimo Corporation Low-noise optical probes
US6541756B2 (en) * 1991-03-21 2003-04-01 Masimo Corporation Shielded optical probe having an electrical connector
US5638818A (en) * 1991-03-21 1997-06-17 Masimo Corporation Low noise optical probe
US6088607A (en) * 1991-03-21 2000-07-11 Masimo Corporation Low noise optical probe
US5782757A (en) * 1991-03-21 1998-07-21 Masimo Corporation Low-noise optical probes
US5602924A (en) * 1992-12-07 1997-02-11 Theratechnologies Inc. Electronic stethescope
US5494043A (en) * 1993-05-04 1996-02-27 Vital Insite, Inc. Arterial sensor
US5337744A (en) * 1993-07-14 1994-08-16 Masimo Corporation Low noise finger cot probe
US5533511A (en) * 1994-01-05 1996-07-09 Vital Insite, Incorporated Apparatus and method for noninvasive blood pressure measurement
US5785659A (en) * 1994-04-15 1998-07-28 Vital Insite, Inc. Automatically activated blood pressure measurement device
US6045509A (en) * 1994-04-15 2000-04-04 Vital Insite, Inc. Apparatus and method for measuring an induced perturbation to determine a physiological parameter
US5590649A (en) * 1994-04-15 1997-01-07 Vital Insite, Inc. Apparatus and method for measuring an induced perturbation to determine blood pressure
US6371921B1 (en) * 1994-04-15 2002-04-16 Masimo Corporation System and method of determining whether to recalibrate a blood pressure monitor
US5791347A (en) * 1994-04-15 1998-08-11 Vital Insite, Inc. Motion insensitive pulse detector
US6852083B2 (en) * 1994-04-15 2005-02-08 Masimo Corporation System and method of determining whether to recalibrate a blood pressure monitor
USD361840S (en) * 1994-04-21 1995-08-29 Gary Savage Stethoscope head
US6678543B2 (en) * 1995-06-07 2004-01-13 Masimo Corporation Optical probe and positioning wrap
US5860919A (en) * 1995-06-07 1999-01-19 Masimo Corporation Active pulse blood constituent monitoring method
US6011986A (en) * 1995-06-07 2000-01-04 Masimo Corporation Manual and automatic probe calibration
US5940182A (en) * 1995-06-07 1999-08-17 Masimo Corporation Optical filter for spectroscopic measurement and method of producing the optical filter
US5743262A (en) * 1995-06-07 1998-04-28 Masimo Corporation Blood glucose monitoring system
US5758644A (en) * 1995-06-07 1998-06-02 Masimo Corporation Manual and automatic probe calibration
US6397091B2 (en) * 1995-06-07 2002-05-28 Masimo Corporation Manual and automatic probe calibration
US5638816A (en) * 1995-06-07 1997-06-17 Masimo Corporation Active pulse blood constituent monitoring
US5760910A (en) * 1995-06-07 1998-06-02 Masimo Corporation Optical filter for spectroscopic measurement and method of producing the optical filter
US5645440A (en) * 1995-10-16 1997-07-08 Masimo Corporation Patient cable connector
US5934925A (en) * 1995-10-16 1999-08-10 Masimo Corporation Patient cable connector
USD393830S (en) * 1995-10-16 1998-04-28 Masimo Corporation Patient cable connector
US5904654A (en) * 1995-10-20 1999-05-18 Vital Insite, Inc. Exciter-detector unit for measuring physiological parameters
US5725480A (en) * 1996-03-06 1998-03-10 Abbott Laboratories Non-invasive calibration and categorization of individuals for subsequent non-invasive detection of biological compounds
US6104938A (en) * 1996-06-12 2000-08-15 Instrumentarium Oy Procedure, apparatus and detector for the determination of fractional oxygen saturation
US5890929A (en) * 1996-06-19 1999-04-06 Masimo Corporation Shielded medical connector
US6027452A (en) * 1996-06-26 2000-02-22 Vital Insite, Inc. Rapid non-invasive blood pressure measuring device
US7041060B2 (en) * 1996-06-26 2006-05-09 Masimo Corporation Rapid non-invasive blood pressure measuring device
US5919134A (en) * 1997-04-14 1999-07-06 Masimo Corp. Method and apparatus for demodulating signals in a pulse oximetry system
US6699194B1 (en) * 1997-04-14 2004-03-02 Masimo Corporation Signal processing apparatus and method
US6229856B1 (en) * 1997-04-14 2001-05-08 Masimo Corporation Method and apparatus for demodulating signals in a pulse oximetry system
US7003339B2 (en) * 1997-04-14 2006-02-21 Masimo Corporation Method and apparatus for demodulating signals in a pulse oximetry system
US6067462A (en) * 1997-04-14 2000-05-23 Masimo Corporation Signal processing apparatus and method
US6184521B1 (en) * 1998-01-06 2001-02-06 Masimo Corporation Photodiode detector with integrated noise shielding
US6597933B2 (en) * 1998-02-11 2003-07-22 Masimo Corporation Pulse oximetry sensor adapter
US6993371B2 (en) * 1998-02-11 2006-01-31 Masimo Corporation Pulse oximetry sensor adaptor
US6349228B1 (en) * 1998-02-11 2002-02-19 Masimo Corporation Pulse oximetry sensor adapter
US6525386B1 (en) * 1998-03-10 2003-02-25 Masimo Corporation Non-protruding optoelectronic lens
US7067893B2 (en) * 1998-03-10 2006-06-27 Masimo Corporation Optoelectronic element with a non-protruding lens
US6714804B2 (en) * 1998-06-03 2004-03-30 Masimo Corporation Stereo pulse oximeter
US6898452B2 (en) * 1998-06-03 2005-05-24 Masimo Corporation Stereo pulse oximeter
US6356774B1 (en) * 1998-09-29 2002-03-12 Mallinckrodt, Inc. Oximeter sensor with encoded temperature characteristic
US6684091B2 (en) * 1998-10-15 2004-01-27 Sensidyne, Inc. Reusable pulse oximeter probe and disposable bandage method
US6735459B2 (en) * 1998-10-15 2004-05-11 Sensidyne, Inc. Reusable pulse oximeter probe and disposable bandage apparatus
US6519487B1 (en) * 1998-10-15 2003-02-11 Sensidyne, Inc. Reusable pulse oximeter probe and disposable bandage apparatus
US6721585B1 (en) * 1998-10-15 2004-04-13 Sensidyne, Inc. Universal modular pulse oximeter probe for use with reusable and disposable patient attachment devices
US6343224B1 (en) * 1998-10-15 2002-01-29 Sensidyne, Inc. Reusable pulse oximeter probe and disposable bandage apparatus
US7044918B2 (en) * 1998-12-30 2006-05-16 Masimo Corporation Plethysmograph pulse recognition processor
US6684090B2 (en) * 1999-01-07 2004-01-27 Masimo Corporation Pulse oximetry data confidence indicator
US7024233B2 (en) * 1999-01-07 2006-04-04 Masimo Corporation Pulse oximetry data confidence indicator
US6996427B2 (en) * 1999-01-07 2006-02-07 Masimo Corporation Pulse oximetry data confidence indicator
US6584336B1 (en) * 1999-01-25 2003-06-24 Masimo Corporation Universal/upgrading pulse oximeter
US6360114B1 (en) * 1999-03-25 2002-03-19 Masimo Corporation Pulse oximeter probe-off detector
US6526300B1 (en) * 1999-06-18 2003-02-25 Masimo Corporation Pulse oximeter probe-off detection system
US6421549B1 (en) * 1999-07-14 2002-07-16 Providence Health System-Oregon Adaptive calibration pulsed oximetry method and device
US6861639B2 (en) * 1999-08-26 2005-03-01 Masimo Corporation Systems and methods for indicating an amount of use of a sensor
US6515273B2 (en) * 1999-08-26 2003-02-04 Masimo Corporation System for indicating the expiration of the useful operating life of a pulse oximetry sensor
US6388240B2 (en) * 1999-08-26 2002-05-14 Masimo Corporation Shielded optical probe and method having a longevity indication
US6580086B1 (en) * 1999-08-26 2003-06-17 Masimo Corporation Shielded optical probe and method
US6542764B1 (en) * 1999-12-01 2003-04-01 Masimo Corporation Pulse oximeter monitor for expressing the urgency of the patient's condition
US6725075B2 (en) * 1999-12-09 2004-04-20 Masimo Corporation Resposable pulse oximetry sensor
US6377829B1 (en) * 1999-12-09 2002-04-23 Masimo Corporation Resposable pulse oximetry sensor
US7039449B2 (en) * 1999-12-09 2006-05-02 Masimo Corporation Resposable pulse oximetry sensor
US6999904B2 (en) * 2000-06-05 2006-02-14 Masimo Corporation Variable indication estimator
US6697656B1 (en) * 2000-06-27 2004-02-24 Masimo Corporation Pulse oximetry sensor compatible with multiple pulse oximetry systems
US6760607B2 (en) * 2000-12-29 2004-07-06 Masimo Corporation Ribbon cable substrate pulse oximetry sensor
US6985764B2 (en) * 2001-05-03 2006-01-10 Masimo Corporation Flex circuit shielded optical sensor
US6850787B2 (en) * 2001-06-29 2005-02-01 Masimo Laboratories, Inc. Signal component processor
US6697658B2 (en) * 2001-07-02 2004-02-24 Masimo Corporation Low power pulse oximeter
US6595316B2 (en) * 2001-07-18 2003-07-22 Andromed, Inc. Tension-adjustable mechanism for stethoscope earpieces
US7030749B2 (en) * 2002-01-24 2006-04-18 Masimo Corporation Parallel measurement alarm processor
US7015451B2 (en) * 2002-01-25 2006-03-21 Masimo Corporation Power supply rail controller
US6850788B2 (en) * 2002-03-25 2005-02-01 Masimo Corporation Physiological measurement communications adapter
US7027849B2 (en) * 2002-11-22 2006-04-11 Masimo Laboratories, Inc. Blood parameter measurement system
US6920345B2 (en) * 2003-01-24 2005-07-19 Masimo Corporation Optical sensor including disposable and reusable elements
US7003338B2 (en) * 2003-07-08 2006-02-21 Masimo Corporation Method and apparatus for reducing coupling between signals

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8135448B2 (en) 2001-03-16 2012-03-13 Nellcor Puritan Bennett Llc Systems and methods to assess one or more body fluid metrics
US20060253016A1 (en) * 2001-03-16 2006-11-09 R Baker Clark Jr Systems and methods to assess one or more body fluid metrics
US9642576B2 (en) 2007-03-09 2017-05-09 Covidien Lp Cancellation of light shunting
US20080220512A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc Tunable laser-based spectroscopy system for non-invasively measuring body water content
US20080221416A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc System and method for detection of macular degeneration using spectrophotometry
US20080221409A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc System and method for controlling tissue treatment
US8690864B2 (en) 2007-03-09 2014-04-08 Covidien Lp System and method for controlling tissue treatment
US20080221410A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc Method for identification of sensor site by local skin spectrum data
US8175665B2 (en) 2007-03-09 2012-05-08 Nellcor Puritan Bennett Llc Method and apparatus for spectroscopic tissue analyte measurement
US8265724B2 (en) 2007-03-09 2012-09-11 Nellcor Puritan Bennett Llc Cancellation of light shunting
US8280469B2 (en) 2007-03-09 2012-10-02 Nellcor Puritan Bennett Llc Method for detection of aberrant tissue spectra
US8346327B2 (en) 2007-03-09 2013-01-01 Covidien Lp Method for identification of sensor site by local skin spectrum data
US20080221412A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc Method and apparatus for spectroscopic tissue analyte measurement
US8923944B2 (en) 2007-03-09 2014-12-30 Covidien Lp Cancellation of light shunting
US8364224B2 (en) 2008-03-31 2013-01-29 Covidien Lp System and method for facilitating sensor and monitor communication
US20090247852A1 (en) * 2008-03-31 2009-10-01 Nellcor Puritan Bennett Llc System and method for facilitating sensor and monitor communication
US8391941B2 (en) 2009-07-17 2013-03-05 Covidien Lp System and method for memory switching for multiple configuration medical sensor
US8417310B2 (en) 2009-08-10 2013-04-09 Covidien Lp Digital switching in multi-site sensor
US9066660B2 (en) 2009-09-29 2015-06-30 Nellcor Puritan Bennett Ireland Systems and methods for high-pass filtering a photoplethysmograph signal
US9649071B2 (en) 2009-09-29 2017-05-16 Nellcor Puritan Bennett Ireland Systems and methods for high-pass filtering a photoplethysmograph signal
US10159412B2 (en) 2010-12-01 2018-12-25 Cercacor Laboratories, Inc. Handheld processing device including medical applications for minimally and non invasive glucose measurements
WO2013077808A1 (en) * 2011-11-25 2013-05-30 Nitto Denko Corporation A method of obtaining a correction factor and a calibration device facilitating performance of said method
US11690566B2 (en) 2017-11-21 2023-07-04 MX3 Diagnostics, Inc. Saliva testing system
US11701036B2 (en) 2019-07-10 2023-07-18 MX3 Diagnostics, Inc. Saliva test strip and method
WO2021146407A1 (en) * 2020-01-15 2021-07-22 MX3 Diagnostics, Inc. Assessment of biomarker concentration in a fluid
US11703436B2 (en) 2020-01-30 2023-07-18 MX3 Diagnostics, Inc. Biological fluid sample assessment

Also Published As

Publication number Publication date
US20040242980A1 (en) 2004-12-02
US7142901B2 (en) 2006-11-28

Similar Documents

Publication Publication Date Title
US7142901B2 (en) Parameter compensated physiological monitor
US7274955B2 (en) Parameter compensated pulse oximeter
US8515514B2 (en) Compensation of human variability in pulse oximetry
US6501974B2 (en) Compensation of human variability in pulse oximetry
US9480422B2 (en) Cyanotic infant sensor
US20230248275A1 (en) Tissue profile wellness monitor
EP1322216B1 (en) A pulse oximeter and a method of its operation
US6421549B1 (en) Adaptive calibration pulsed oximetry method and device
US6104938A (en) Procedure, apparatus and detector for the determination of fractional oxygen saturation
US6842635B1 (en) Optical device
US5842979A (en) Method and apparatus for improved photoplethysmographic monitoring of oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin
US8385995B2 (en) Physiological parameter tracking system
US8109882B2 (en) System and method for venous pulsation detection using near infrared wavelengths
US20080132771A1 (en) Measurement of blood oxygen saturation
US20030109776A1 (en) Adaptive calibration pulsed oximetry method and device
US20060052680A1 (en) Pulse and active pulse spectraphotometry
EP1771109B1 (en) Cyanotic infant sensor

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION